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Human beings are members of a whole, 
In creation of one essence and soul. 
If one member is afflicted with pain, 
Other members unease will remain. 
If you have no sympathy for human pain, 
The name of human you cannot retain. 
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Many cellular processes involve molecular interactions at the cell membrane. Due 
to the complexity of living cells, these interactions are usually studied on model 
membranes. This thesis introduces two platforms based on model membranes for 
studying biological interactions and processes on cell membranes.  
In the first part of this thesis, we employed planar lipid bilayers to develop a 
novel, label-free, and sensitive assay for monitoring the activity of phospholipases D and 
C that are critical for cell signaling. The activities of these enzymes typically change the 
surface charge of the membrane. The present assay employs the ion channel-forming 
peptide gramicidin A to probe these changes and, hence, to monitor the activity of these 
phospholipases in situ and in real-time. Quantitative results from this assay, allowed us to 
investigate the kinetics of the heterogeneous catalysis of these enzymes. 
In addition we applied this gramicidin-based sensor to monitor the binding of two 
therapeutic drugs to various bilayers. Quinine, an anti-malaria agent, and imipramine, an 
anti-depressant, are positively-charged under physiological conditions and, once bound to 
a membrane, alter the membrane surface charge. The present assay probes these changes 
and makes it possible to quantify these binding events.  
In the second part of this work, we developed a technique that employs 
topographically-patterned hydrogel stamps to fabricate arrays of membranes and 
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membrane proteins for screening of membrane interactions. This method takes advantage 
of the porous, hydrated, and biocompatible nature of hydrogels to print spatially-
addressable arrays of membranes in a rapid and parallel fashion. We employed this 
method for two distinct approaches; one approach takes advantage of the storage 
capability of agarose stamps and minimizes the required time and amount of membrane 
preparations by generating multiple copies of a membrane array. The other approach 
takes advantage of on-stamp preconcentration of cellular membrane fragments to 
generate arrays of multilayered-membranes with high contents of proteins and enhances 
detection sensitivity. We used these arrays for screening the interactions of a protein 
(annexin V) and an anti-inflammatory drug (nimesulide) with various bilayers. We also 
carried out ligand-binding assays on these arrays and showed that the stamped membrane 




Chapter 1  
Introduction and Background 
 
All prokaryotic and eukaryotic cells are surrounded with a plasma membrane that 
not only defines the shape and structure of the cell but also acts as a selective barrier with 
a crucial role in communication between the inside and outside of the cell.1-3 Many of 
fundamental processes in cells such as signal transduction and cell proliferation involve 
membranes at some point. Biomembranes have, consequently, been implicated in a 
variety of disease states including cancer4 and Alzheimer’s disease.5,6 Interest in 
biomembranes, their function, and their dynamics have constantly grown in a number of 
fields including biology, biochemistry, biophysics, immunology, and pharmacology. 
Elucidating cellular mechanisms by studying different aspects of membranes on natural 
cell membranes is extremely difficult due to the complexity of living systems and hence, 
benefits from representative model membranes.1,3 These model membranes can be 
categorized into three main groups of lipid monolayers, lipid bilayers,1 and lipid 
vesicles.7  
This thesis describes two novel platforms based on lipid bilayer model 
membranes for studying molecular processes and interactions on membranes. The first 
part of this work presents an ion channel-based sensor for monitoring the activity of 
membrane-active enzymes and for binding of bioactive molecules at the surface 
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membranes. The second part of this work introduces a straightforward approach to 
fabricate arrays of lipid bilayers and arrays of membrane proteins for screening of lipid-
protein interactions and drug-membrane interactions. 
In the following chapter, this introduction focuses first on a general background on 
biological membranes and model membranes by discussing “Biological and Model 
Membranes”, and then it focuses on the two parts of the thesis by discussing the two 
following topics: 
• “Planar Lipid Bilayer Systems for Sensing Membrane Interactions”   

















1.1. Biological and Model Membranes 
1.1.1. Historical View on Biological Membranes  
In the mid-nineteenth century, Wilhelm Pfeffer, a plant physiologist, recognized 
the presence of a semipermeable membrane around the cytoplasm while he was studying 
osmosis in plant cells.1,3 Later, additional evidence confirmed the existence of a selective 
barrier around the cell, the so called the plasma membrane,.  
Soon after this discovery, work by Overton on the flux of different molecules into 
cells provided evidence for the lipid nature of cell membranes.1,3,8 In his studies, Overton 
found a strong correlation between the influx of molecules into cells and their partition 
coefficient between oil and water.  
In 1925, Gorter and Grendel showed that lipid molecules in an erythrocyte cell 
membrane form a bimolecular (bilayer) structure.1,3,8 Despite all the later modifications 
of this model, the basic lipid bilayer structure of membranes proposed by Gorter and 
Grendel has remained unchanged ever since.  
In 1935, Davson and Danielli proposed a model in which proteins coated the 
surfaces of the lipid bilayer and formed a three-layered protein-lipid bilayer-protein 
structure.1,3,8 While accepted for the next 30 years, this model was slightly modified to 
account for the functional diversity in membranes. 
In 1970, Singer and Nicolson proposed the fluid mosaic model9 that described the 
membrane as a fluid lipid bilayer in which proteins are embedded and can diffuse 
freely.1,3,8 The fluid mosaic model was the first model to address the fluidity of natural 
membranes. Within the past few decades, extensive research on membranes demonstrated 
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the complexity of natural membranes compared to the simple fluid mosaic model and led 
to several modifications of this model. Table 1-1 shows an overview of the experimental 
evolution that led to the current understanding of biomembranes as summarized by Tien 
et al..1 
 
Table 1-1. The lipid bilayer concept and its experimental evolution. This table is taken from Tien 
et al. 1 and the references refer to the citations of original work. 
 
 
The present view of biomembranes, proposes that the basic structure of all 
membranes is a lipid bilayer assembly in which lipid molecules can diffuse. Embedded 
in, or peripherally associated with, this fluid lipid bilayer are many other components 
including proteins and carbohydrates.  
Moreover, that natural membranes exhibit transverse and lateral asymmetry that is 
important for their function.3 Recently, it has become clear that the composition of 
membranes (in terms of type and ratio of lipids, proteins, and hydrocarbons) varies 
significantly from one cell type to another, depending on the functional role of the 
5 
 
membrane.3 The function of the vast number of different lipids is not fully understood; 
the novel field of lipidomics attempts to elucidate these functions.3 
 
1.1.2. Membrane Components  
Plasma membranes are composed of three major components: lipids, proteins, and 
carbohydrates.10  
Bilayer-forming lipids are amphiphilic molecules that self assemble into a bilayer 
structure with their hydrophobic fatty acyl chains associated together in the interior of the 
bilayer and their polar headgroups facing the aqueous environment on either side of the 
bilayer.  
In most natural membranes, proteins constitute the largest weight fraction of the 
membrane. Membrane proteins can be grouped into two distinct categories of integral 
proteins and peripheral proteins. Integral or transmembrane proteins contain hydrophobic 
domains which enable them to pass through the hydrophobic core of the lipid bilayer, 
whereas peripheral proteins only bind to the surface of the membrane.  
Carbohydrates, that form the third major component of biomembranes, are often 
coupled to lipid or protein molecules forming glycolipids and glycoproteins. Glycolipids 
and glycoproteins are usually found on the outer leaflet of cell membranes with their 





Figure 1-1. Current understanding of the fluid mosaic model for biomembranes, which shows the 
lipid bilayer in more detail (different lipid species are shown in different colors) with associated 
membrane proteins and carbohydrates. This figure is adopted from Edinin et al. 8. 
 
1.1.3. Model Membranes  
The significant role of biomembranes in biology has driven the development of 
several experimental models for studying biomembranes. These model membranes 
include lipid monolayers, planar lipid bilayers,1,11 supported lipid bilayers,2,10,12 and lipid 
vesicles.1,7 Each of these model membranes has advantages and disadvantages as 
discussed below.  
Lipid monolayers, referring to a single layer of lipid molecules that self assemble 
at the air-water interface, comprised the first model membrane developed for studying 
different aspects of biomembranes.1 Given the fundamental lipid bilayer structure in all 
biomembranes, lipid monolayers mimic only half of a natural membrane and hence, are 
not ideal models. Models based on a lipid bilayer, therefore, resemble natural membranes 
better than those based on lipid monolayers.  
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Planar lipid bilayers are free-standing lipid bilayers that typically span over a 
small pore in a hydrophobic partition between two aqueous compartments (Figure 1-
2).1,2,11 Electrical access to both sides of these bilayers makes them well suited for 




Figure 1-2. Schematic representation of a planar lipid bilayer. These lipid bilayers typically span 
a pin hole with a diameter of 1-1000 μm in a hydrophobic support.  
 
In supported lipid bilayers, a solid substrate that supports the lipid bilayer (Figure 
1-3), provides mechanical stability and makes these systems one of the most robust yet 
fairly realistic models for biological membranes.1,2,10,14,15 The applicability of surface 
detection methods in these systems, makes them particularly attractive for studying 
molecular interactions at the membrane.2,10,16 The main drawback of these models is 
undesired interactions between the membrane components (e.g. lipids and proteins) with 







Figure 1-3. Schematic diagram of a solid-supported lipid bilayer.  
 
Lipid vesicles, also called liposomes, are spherical shells made of a lipid bilayer 
(Figure 1-4).1 Among the present model membranes, liposomes mimic the inherent 
spherical shape of natural membranes the best. These membranes are particularly useful 
for biophysical studies of biomembranes such membrane fusion,17 curvature,18 and 










While the bilayer in these model membranes is free-standing, lack of electrical 
access to both sides of the bilayer limits the application of vesicles in electrical probing 




1.2. Planar Lipid Bilayer Systems for Sensing Membrane Interactions   
This part of the introduction focuses on planar lipid bilayers as model membranes 
and discusses the fabrication, characterization, and some of the applications of these 
model membranes. At the end of this section, the main goal of the first part of this thesis 
is discussed.  
In the 1960s Muller et al. developed the first planar lipid bilayer system to 
investigate the electrical properties of a bilayer.21,22 In this system a lipid bilayer is 
suspended over a small hole in a partition between two compartments with aqueous 
solutions. Electrical access to both sides of the bilayer in these systems makes these 
platforms attractive for electrophysiological studies. Compared to solid-supported 
bilayers, these free-standing bilayers avoid direct interactions with an underlying 
substrate and hence, are advantageous for investigation of integral membrane proteins 
(e.g. ion channels).2,11 These bilayers have, however, limited lifetime (typically a few 
hours) due to their poor mechanical stability.2 This short-term stability limits the 
application of planar lipid bilayers to relatively short experiments in a controlled 
laboratory environment. Several recent developments have addressed this issue and 
strengthened these bilayers. Examples of such strategies include: employing micro pores 
with diameters below 15 μm23-25 and sandwiching bilayers between hydrogels.26-28  
 
1.2.1. Fabrication of Planar Lipid Bilayers  
While several different techniques generate planar lipid bilayers, traditional 




In the “painting” method21 a free-standing lipid bilayer is formed by painting a 
concentrated solution of lipids dissolved in an organic solvent over a small orifice (sub-
millimeter diameter) in a nonpolar septum (e.g. Teflon) which separates two aqueous 
compartments. As the excess solvent disperses to the rim of the pore in the nonpolar 
septum, lipid molecules self-assemble to a bilayer structure across the orifice.  The 
“painting” method, developed by Mueller and Rudin,21 has a drawback of producing 
bilayers that contain uncertain amounts of solvent, such as decane or heptane.  
In the “folding” technique,29 a lipid bilayer forms over a small orifice in a 
nonpolar septum from opposing two lipid monolayers that were previously formed at an 
air-water interface. Although in comparison with painted bilayers, folded bilayers are 
often named “solvent-free”, these bilayers also contain small traces of the organic solvent 
that is required to pretreat the pore (typically hexadecane or squalene).11  
 
1.2.2. Biophysical Characterization of Planar Lipid Bilayers 
Formation of planar lipid bilayers can be followed by optical microscopy.2,3,11 
Observing this process by an optical microscope for the first time, Mueller et al. noted 
that as the bilayer thins out, a black spot gradually spreads over the film resulting in a 
black lipid bilayer at the end.21,22 This dark appearance is due to the destructive 
interference of the reflected light from water-lipid interface and the phase-shifted light 
from the lipid-water interface.2,11 Referring to their appearance under optical microscopy, 
the term black lipid membrane (BLM) is also used for planar lipid bilayers.2,3,11 
Planar lipid bilayers are usually probed for their electrical characteristics (e.g. 
capacitance and conductance). A lipid bilayer is an insulator with a specific capacitance 
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of 0.6-1 μF cm-2.11,24 As a result, even a slight defect or pore in the bilayer can be 
detected by an increase in conductance. Given an estimate of bilayer surface area, the 
thickness of the bilayer can also be monitored through its capacitance.  
 
1.2.3. Planar Lipid Bilayers for Membrane Studies 
Planar lipid bilayers are particularly attractive platforms for electrical 
measurements across the membrane.1-3,11 Since their development, these model 
membranes have been used for studies of different membrane-active molecules such as 
peptides,30 proteins,31,32 and other ion channel-forming biomolecules. These membranes 
have also been employed for discovery of channel blockers and possible new 
therapeutics.33,34  
In recent years, planar lipid membranes with embedded protein pores have 
received increasing attention for the development of chemo- and biosensors.2,23,35 Among 
current applications of these channel-based sensors are: monitoring protein-ligand 
interactions,13,36,37 monitoring chemical reactions,38,39 pH-sensing,40 probing surface 
charge,41-43 and detection of binding and unbinding of organic molecules into modified 
protein channels.44-46 Protein pores commonly used for these sensors include 
alamethicin,13 α-hemolysin,45-53 and gramicidin channels.36-38,40-42  
The goal of the first part of this thesis was to develop an ion channel-based sensor 
to monitor the activity of surface-active enzymes and other membrane active compounds. 
To address this goal, we introduced a gramicidin-based assay to monitor and quantify the 
activity and enzyme kinetics of two membrane-active enzymes, phospholipases C and D, 
on planar lipid bilayers (chapters 2 and 3). We also present a gramicidin-based platform 
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to screen and quantify the binding of bioactive molecules including therapeutic 
compounds to lipid bilayers (chapter 4).  
Gramicidin A is a natural channel-forming peptide with a molecular weight of 
1.9 kDa that is secreted from the bacterium Bacillus brevis.54 This small peptide self-
incorporates into lipid bilayers and upon a reversible head-to-head dimerization forms an 
aqueous pore with a diameter of 4 Ǻ and a length of 25 Ǻ through the bilayer.54 The 
channel forming kinetics of gA pores in a lipid bilayer are evidenced by stepwise changes 
in conductance, where each step increase illustrates the formation of one gA pore and 
each step decrease shows the dissociation of a pore. Gramicidin channels are cation 
selective and facilitate the transmembrane flux of monovalent cations.54,55  
Previous work on gA pores has demonstrated that the kinetics of gA channels 
such as their lifetime and opening frequency, depend strongly on the recording buffer as 
well as the composition of the lipid bilayer that surrounds the channel.41,56 These kinetics 
can, hence, reveal information about the environment surrounding the gA channel. As a 
result, gA channels, in native and chemically derivatized form, have attracted increasing 
interest as nanosensors to sense membrane surface charge,42,43 pH at the membrane 
surface,40 ligand-protein interactions,36,37 lipid-protein interactions,57 and chemical 
reactions that lead to derivatization of the  which a gA derivative.38,39      
Here we present the first attempt to employ native gramicidin channels to 
monitor, in situ and in real time, the activity of membrane-active enzymes on membranes 
and to screen binding of bioactive compounds to lipid bilayers. This part of the thesis 
addresses the following specific aims within the chapters 2 to 4: 
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• Chapter 2 and 3: To develop a sensitive, label-free, and quantitative assay that 
proceeds in situ an in real time to monitor the enzymatic activity of membrane-
active enzymes. To employ the results of this assay to investigate the kinetics of 
heterogeneous catalysis of these surface-active enzymes by elucidating kinetic 
constants. 
• Chapter 4: To develop a novel, label-free, and quantitative platform to detect 
binding of membrane active molecules to planar lipid bilayers, and to demonstrate 




1.3. Arrays of Supported Membranes for Screening Membrane Interactions 
This part of the introduction focuses on supported lipid membranes and arrays of 
supported membranes as model membranes, and discusses the fabrication, 
characterization, and some of the applications of these model membranes. At the end of 
this section, the main goal of the second part of this thesis is discussed.  
Unlike planar lipid bilayers, supported lipid bilayers are mechanically stable. 
While the supporting substrate provides unique mechanical stability for these lipid 
bilayers, the presence of a thin (1-2 nm) layer of water between the lipid bilayer and the 
substrate retains the mobility of lipid molecules within these model membranes.15,58 In 
addition, supported membranes are accessible to a wide range of surface-specific 
analytical techniques, such as atomic force microscopy (AFM),59,60 surface plasma 
resonance (SPR),16 and total internal reflection (TIRF) microscopy.16 Since their 
development by Tamm and McConnell in the 1980s,15 supported lipid bilayers have 
received increasing attention as one of the most robust yet realistic models for natural 
membranes.2,14,16,61,62 
Supported lipid bilayers form and remain on solid supports due to a number of 
different forces, including van der Waals, electrostatic, hydration, and steric forces.2,12,63-
65 In these systems, therefore, surface properties of the substrate are crucial and strongly 
influence the quality of the bilayer. Studies have shown that bilayers of high quality (with 
minimal defects) and high lipid mobility form on hydrophilic and clean surfaces.2,12 
Examples of hydrophilic substrates that are commonly used in this field include glass,15 
quartz,15 mica,66 and oxidized silicon.15 Although these surfaces can support fluid and 
defect-free bilayers, they are not ideal substrates for bilayers that contain transmembrane 
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proteins with large peripheral domains.2,61,67 If the peripheral domain of a protein exceeds 
1-2 nm (the thickness of the water film between  the bilayer and the supporting substrate), 
then the protein is likely to interact with the substrate which can cause an irreversible 
denaturation of the protein.2 Researchers have addressed this issue by developing 
polymer cushioned supported bilayer systems in which a cushion of polymer on the 
substrate elevates the bilayer to provide space for the peripheral domains of integral 
proteins (Figure 1-5).67-69 This cushion, hence, protects the protein from direct 
interactions with the substrate. Various polymer cushions have been employed for this 
purpose, as summarized by Castellana et al.,2 these include “dextran, cellulose, chitosan, 




Figure 1-5. Peripheral domains of transmembrane proteins can become immobilized and 
denatured on a solid support. A polymer cushion helps shield the protein from the substrate. This 




1.3.1. Formation of Supported Lipid Bilayers 
Supported lipid bilayers can be formed by three main techniques ,including the  
Langmuir-Blodgett/Langmuir-Schaefer method,15,70 the vesicle fusion method,71 and the 
Langmuir-Blodgett/vesicle fusion method.72  
The Langmuir-Blodgett/Langmuir-Schaefer (LB/LS) technique, developed by 
Tamm and McConnel in 1984,15,70 is the oldest method of fabricating solid-supported 
lipid bilayers. This technique forms a lipid bilayer in two steps. First, a lipid monolayer is 
formed by spreading lipids at an air-water interface, 73 and a clean, hydrophilic substrate 
is vertically pulled through this lipid monolayer. This process leads to deposition of the 
first leaflet of the bilayer onto the substrate (LB method). In the second step, the 
substrate, already coated with one monolayer, is horizontally pushed through another 
lipid monolayer at the air-water interface (LS method), completing the formation of a 
lipid bilayer on the surface (Figure 1-6a). This technique can create bilayers with 
transverse asymmetry.74 Also, incorporation of small peptides into the first or second 
monolayer at the air-water interface results in a supported lipid bilayer that contains these 
peptides. Incorporation of large transmembrane proteins, however, is not feasible by this 
method due to the possible exposure of proteins to air and their consequent 
deactivation.72  
Vesicle fusion71,75 is the simplest and most common method for the formation of 
supported lipid bilayers.2 In this method, a solution of small or large unilamellar 
liposomes is exposed to a clean, hydrophilic surface for 1–60 min. At the end of the 
incubation time, excess liposomes are washed away, leaving behind a supported lipid 
bilayer behind (Figure 1-6b). Incorporation of membrane proteins into these membranes 
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is, in principle, relatively straightforward and only requires application of 
proteoliposomes (liposomes that contain integral membrane proteins) instead of pure 
liposomes.76 Moreover, polymer cushioned supported bilayers can be fabricated using the 
vesicle fusion method by replacing the bare substrate with a polymer-coated substrate. 
The liposomes and proteoliposomes used in this technique can be prepared in various 
ways including sonication77 and extrusion78 for liposomes and the detergent-dialysis 




Figure 1-6. Common techniques for the formation of supported lipid bilayers. (a) The Langmuir–
Blodgett technique is carried out by pulling a hydrophilic substrate through a lipid monolayer 
followed by the Langmuir-Schaefer technique that involves pushing the substrate horizontally 
through another lipid monolayer. (b) In the vesicle fusion method, vesicles in solution adsorb and 
spontaneously fuse to the surface to form a solid supported lipid bilayer. (c) The Langmuir-
Blodgett/vesicle fusion is a combination of the Langmuir–Blodgett and vesicle fusion processes. 
This figure is taken from Castellana et al.2. 
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In vesicle fusion, vesicles (also called liposomes) first adsorb to the surface, fuse 
with each other, and then rupture and spread on the surface, creating small patches of 
lipid bilayers.2,12,65 Coalescence of these small bilayer patches forms a large and 
continuous lipid bilayer (Figure 1-7).12,63,64,79,80 Despite attempts to understand the exact 
mechanism of this process, vesicle fusion on hydrophilic surfaces is still not completely 
understood. Considerable work on this topic has, however, revealed a number of factors 
that affect the progression of each of the adsorption, fusion, and spreading steps. These 
factors, as stated by Castellana et al.,2 include ”the vesicle composition, size, surface 
charge, surface roughness, surface cleanliness, solution pH, ionic strength, and the 





Figure 1-7. Schematic of the proposed mechanism of formation of lipid bilayer in vesicle fusion 
method. Adsorbed vesicles fuse with themselves until a critical size is reached and then rupture to 




Due to the coalescence mechanism of bilayer formation, the vesicle fusion 
technique often produces bilayers with more defects compared to those produced by 
LB/LS method. This technique is also usually limited to the production of symmetric 
lipid bilayers.  
The combination of the two aforementioned techniques results in the Langmuir-
Blodgett/vesicle fusion method for fabrication of supported lipid bilayers.72 Similar to the 
LB/LS method, this method creates a supported lipid bilayer in two steps. In the first step, 
a lipid monolayer is transferred from the air-water interface to the substrate by the LB 
technique. In the second step, fusion of liposomes onto the monolayer-coated substrate 
forms the upper leaflet of the bilayer.  
This method is unique in that it has advantages of both the LB/LS and the vesicle 
fusion methods. For instance, compared to vesicle fusion, this technique forms bilayers 
with fewer defects and can create lipid bilayers with transverse asymmetry in lipid 
composition.81 Furthermore, transmembrane proteins can be incorporated into these 
supported membranes72 in the second step by fusing proteoliposomes to form the second 
leaflet of the bilayer, although not all proteins may remain functional during the process.  
 
1.3.2. Biophysical Characterization of Supported Lipid Bilayers 
Supported lipid bilayers are often characterized in terms of their quality, structure, 
fluidity, and electrical properties.  
One of the most common techniques for probing the overall quality of supported 
bilayers is epifluorescence microscopy.2 This comparably simple microscopy method is 
useful in detecting large (i.e. micrometer sized) inhomogeneous and defective areas 
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within a supported membrane; it requires to add a small fraction (typically ≤1 mol%) of a 
fluorescently-labeled lipid to the bilayer.  
Detection of nanometer-size defects, however, is not feasible by epifluorescence 
microscopy and necessitates higher-resolution imaging techniques such as atomic force 
microscopy (AFM).59,66 This type of microscopy probes the height profile of the 
membrane on the surface and is commonly used to monitor nanometer-size defects in 
supported bilayers.59 This unique approach also distinguishes between single bilayer and 
multiple bilayer structures in a supported membrane and can detect lateral phase 
separation in lipid bilayers.60  
Structural details, such as transverse or lateral organization of supported bilayers, 
can be studied with a number of different techniques including neutron reflectivity,58 
Fourier transform infrared spectroscopy (FTIR),82 sum frequency vibrational 
spectroscopy (SFVS),83 and fluorescence interface contrast microscopy (FLIC).81 
Fluidity is one of the key features of natural membranes and its changes influence 
important physiological functions such as signal transduction.84,85 Thus, to resemble 
natural membranes, model membranes such as supported lipid bilayers should be fluid. 
The significance of fluidity in membranes has driven the development of several 
techniques for measuring membrane fluidity. Fluorescence recovery after photobleaching 
(FRAP)60 is one of the most common methods for quantifying lateral diffusion in cell 
membranes as well as in model membranes. In this method, a beam of high-intensity light 
(ideally from a laser) is used to photobleach, irreversibly, a population of fluorophores in 
a small region within a fluorescently-labeled membrane. Recovery of fluorescence in the 
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bleached area due to the lateral diffusion of intact, fluorophore-labeled lipids is then 
monitored and used to calculate the diffusion coefficient, D, of the lipids.86,87 
Other techniques to probe membrane fluidity include fluorescence anisotropy,88 
environmentally-sensitive fluorescent probes (i.e. molecular rotors),89 fluorescence 
correlation spectroscopy (FCS),87 and single particle tracking (SPT).90 
 As mentioned before, a lipid bilayer is an excellent electrical insulator with a 
specific capacitance of 0.6-1 μF cm-2.3 In natural membranes, however, a variety of 
channels and pores embedded in the lipid bilayer facilitate the transport of ions and 
determine the overall conductance of the cell membrane. In model lipid membranes 
without embedded channel proteins, therefore, any change in conductance is a measure of 
existing defects in the bilayer.11 While for most current applications of supported lipid 
bilayers, electrical properties and conductance of the bilayer are not critical, for some 
applications such as sensor development,2,62 these properties are important. The electrical 
characterization of supported lipid bilayers is often conducted by impedance 
spectroscopy.91,92 In this method, the target lipid bilayer is supported by a conductive 
substrate (e.g. gold) that acts as an electrode. A second electrode is placed in the aqueous 
media around the bilayer and the impedance of the system is measured for an applied 
A/C voltage in a range of frequencies. Electrical properties of the bilayer (including its 
capacitance and conductance) are then determined by evaluating the entire electrical 
circuit in the system.91 For the evaluation, the lipid bilayer in this electrical circuit is 




1.3.3. Supported Lipid Bilayers for Membrane Studies 
Interest in supported lipid bilayers includes studies on the dynamic structure of 
membranes,58,69 lipid-protein interactions,69 ligand-receptor interactions,16,69,93,94 
development of membrane-based biosensors,2,14,62,95,96 and drug discovery.97 Selected 
examples of applications of supported bilayers in these studies are discussed below.  
Studies on lipid rafts are often performed on supported lipid bilayers. Lipid rafts, 
i.e. cholesterol and sphingolipid (SL) enriched domains in the plasma membrane,19,60,98,99 
attract much interest due to their possible role in a broad range of biological processes 
and, hence, in a number of diseases.100-102 Several research groups have investigated 
phase separation and formation of raft-like lipid domains in supported lipid bilayers by 
epifluorescence microscopy, atomic force microscopy (AFM),59,60 and near-field 
scanning optical microscopy (NSOM).99  
Research on membrane fusion has also employed supported membrane 
platforms.103,104 Understanding the mechanism of membrane fusion is important due to 
the central role of this process in events such as vesicle trafficking, membrane biogenesis, 
fertilization, and virus entry.103,104 Recently, several groups have studied protein-
mediated fusion of vesicles with supported lipid bilayers by surface-sensitive techniques 
such as total internal reflection fluorescence microscopy (TIRFM)103 and Fourier 
transform infrared (FTIR) spectroscopy.104 
Interactions between proteins and lipids influence the function of both the 
proteins and the lipids and are thus critical for many cellular functions.16,105 These 
interactions in supported lipid bilayers have been studied by a number of techniques such 
as epifluorescence microscopy,106 atomic force microscopy (AFM),107,108 surface plasma 
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resonance (SPR),16,109 impedance spectroscopy,109 total internal reflection fluorescence 
microscopy (TIRFM),16 attenuated total reflection FTIR spectroscopy,16 and fluorescence 
resonance energy transfer (FRET).110 Such interactions have also been investigated by 
monitoring lateral diffusion of lipids and proteins by techniques such as fluorescence 
recovery after photobleaching (FRAP)111-113 and fluorescence correlation spectroscopy 
(FCS).114   
 
1.3.4. Arrays of Membranes and Membrane Proteins 
Membrane arrays provide a unique platform to study different aspects of 
membranes with various compositions under identical conditions and in a parallel 
fashion. These arrays are, hence, of interest for performing multiplexed, high-
information-content assays in both academic and industrial membrane 
research.94,97,113,115,116 Arrays of lipid membranes with and without functional 
transmembrane proteins have been applied for investigating lipid-protein interactions,106 
protein-protein interactions,113 and drug-membrane interactions.97,115,116 Due to the 
medical significance of transmembrane proteins, as the largest group of current 
therapeutics targets,116,117 arrays of membrane proteins are particularly attractive for the 
pharmaceutical industry. Therefore, the ability to pattern arrays of membranes and 
membrane proteins has become essential. 
Arrays of supported lipid bilayers can be produced by different approaches as 
briefly described here. In one such method, arrays of lipid bilayers can be formed by 
fusing lipid vesicles onto a partitioned substrate. This technique requires substrates with 
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patterned barriers, which can be made by standard photolithography118,119 or microcontact 
printing with poly(dimethylsiloxane) (PDMS)120 stamps.121,122  
Alternatively, arrays of membranes can be created from an existing continuous 
membrane. Using this approach, a membrane array can be produced when a 
topographically patterned PDMS stamp removes selected areas of a continuous bilayer. 
This process is followed by adsorption of a protein, as a barrier, onto these cleared 
areas.121,122  
Formation of an array of lipid bilayers from a continuous bilayer can also be 
addressed by erasing selective regions of a bilayer by high intensity deep-UV 
illumination through a photomask under aqueous solution.123  
Furthermore, creating membrane arrays from a continuous membrane can be 
accomplished by the polymer lift-off method.124,125 In this method, a thin patterned film 
of polymer is first deposited onto the substrate and after formation of a continuous bilayer 
on the substrate, the film is peeled off to leave behind an array of bilayers. 
As a third approach, microcontact printing by PDMS stamps can print arrays of 
lipid bilayers on bare substrates. In this technique, plasma oxidation of the PDMS stamp 
renders the surface of the stamp hydrophilic; a supported lipid bilayer is formed on the 
PDMS stamp by vesicle fusion and then is transferred to a clean substrate upon short and 
close contact to transfer an array of bilayers onto this substrate.122 As mentioned 
previously, a PDMS stamp can also remove selective regions of an existing supported 




While useful for some applications, these established techniques are limited in 
their ability to vary the membrane composition from one spot to another within one array.  
Considering the main advantage of membrane arrays, i.e. providing a platform for 
parallel studies on various membrane compositions in parallel, arrays of membranes with 
various membrane compositions present a more attractive class of membrane arrays in 
this field. Existing methods to fabricate such “multi-composition” arrays include: 
i) Selective photobleaching of lipid bilayer spots in an array of identical lipid bilayers to 
produce an array of bilayers with limited differentiation in composition of 
photobleached and non-photobleached fluorescent lipids (Figure 1-8a).126,127    
ii) Microcontact printing of spots of bilayers of the same composition but different sizes 
onto a substrate with patterned corrals. Backfilling these corrals with a solution of 
vesicles of a different composition results in an array of lipid bilayers with a gradient 






Figure 1-8. (a) Composition array generated by photopatterning. A mask is used to selectively 
bleach different-sized areas of a membrane array. After diffusive mixing within each corral, a 
concentration array is observed. (b) Concentration arrays fabricated by microcontact printing of 
different-sized bilayer patches. After printing, the empty space in each corral is backfilled with 
small unilamellar vesicles (SUV) to form a continuous bilayer in each corral. Shown here is an 
epifluorescence image of printed Texas Red labeled membranes backfilled with Cascade Blue 
labeled lipids. The red image is shown on the left and the blue on the right. This figure is taken 
from Castellana et al.2. 
 
iii) Flowing of two different liposome solutions within the laminar flow regime inside a 
microfluidic channel (with a wall of patterned glass) to produce arrays of membrane 
spots with a gradient in their lipid components that depends on the position of the 






Figure 1-9. Concentration array formed by laminar flow in a microfluidic channel. Diffusive 
mixing in a microchannel under laminar flow conditions provides a concentration gradient of 
different dye-labeled vesicles. The concentration of vesicles in the gradient is reflected by the 
surface concentration of each membrane in the resultant array. The array shown is a mixture of 
Texas Red labeled lipids (shown in red) and NBD labeled lipids (shown in green). Since the dyes 
have opposite charges, they can be separated in an electric field as shown in the panel on the 
right. This figure is taken from Castellana et al.2. 
 
iv) Pipetting of small droplets of different liposome solutions into individual corrals of a 
substrate with patterned barriers (Figure 1-10).129 Compared to the other methods, 
this method has the capability to create membrane arrays with an unlimited number of 
compositions. Production of membrane arrays by this method has been facilitated by 





Figure 1-10. Array fabricated by pipetting of individual liposome solutions. A pulled 
microcapillary tip is used to fill individual corrals on a pre-patterned substrate. This figure is 
adopted from Castellana et al.2. 
 
Given the application of membrane arrays in today’s academic and 
pharmaceutical research, an ideal fabrication method would create arrays of fluid lipid 
bilayers with various compositions in a rapid and parallel fashion without the need for 
patterning the substrate and with minimal consumption of lipid preparations. As 
described above, all current techniques with the capability of producing membrane arrays 
with various compositions require substrates with patterned corrals. Among these 
techniques, deposition of small droplets of vesicle solutions64 onto a patterned substrate is 
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the only approach that allows fabrication of arrays with a large number of membrane 
compositions. This technique, however, transfers bilayers in a serial fashion (which in 
case of large and complex arrays can be time-consuming) unless combined with a quill 
pin printer.113  
Despite the usefulness of the established techniques for production of arrays of 
lipid bilayers, not all of these methods are applicable for fabrication of arrays of lipid 
bilayers that contain membrane proteins. Fabrication of membrane protein arrays is much 
more challenging than fabrication of arrays of lipid bilayers due to the fragile nature of 
these proteins. This fragility requires membrane proteins to be embedded in a membrane 
environment in order to maintain their native conformations.94,115,116  
Currently, arrays of membrane proteins are fabricated by deposition of small 
droplets of a proteoliposome solution onto surfaces.94,115,116 This technique is able to 
create arrays with numerous different membrane proteins. In addition, robotic technology 
has turned this otherwise serial and time-consuming printing approach to a parallel and 
rapid approach.94,115,116 The additional cost of robotic technology, however, limits its 
application in academic research laboratories. In addition, this method deposits nanoliter 
volumes of membrane preparations, which might lead to drying of the membranes and 
associated damage to the proteins, unless a controlled humidity environment is 
maintained.   
The goal of the second part of this thesis was to develop a novel and 
straightforward technique to fabricate spatially addressable arrays of membranes and 
membrane proteins for screening molecular interactions on membranes. This technique 
should ideally meet the following requirements: 
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• produce arrays of fluid and functional membranes with and without integral 
membrane proteins. 
• Transfer membrane arrays without the need for patterned substrates (ideally 
applicable on bare and coated surfaces).  
• create arrays of membranes of various compositions (with no limitation in the 
number of components, including type of lipid and protein). 
• pattern membrane spots of an array in a rapid and parallel fashion. 
• prevent dehydration and denaturation of lipids and proteins during the fabrication 
process. 
• minimize the consumption of precious membrane preparations.  
• be low-tech and applicable even in a small research laboratory with limited 
resources. 
• be expandable to automated and robotic formats for industrial applications. 
 
To meet these characteristics, we introduce hydrogel-based microcontact printing 
for fabrication of arrays of supported lipid bilayers of well-defined compositions (chapter 
5). We also introduce a novel approach for fabrication of membrane protein microarrays 
using hydrogel-based microcontact printing (chapter 6). In chapters 5 and 6, we discuss 
whether this novel approach meets presented approaches for all of the aforementioned 
requirements.  
Microcontact printing by poly(dimethylsiloxane) (PDMS) stamps was developed 
originally to pattern non-polar alkane thiols onto gold surfaces.120 Since then, this 
patterning method has found wide application in different fields such as material 
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science.2 The stamps used are fabricated by molding PDMS against a lithographically 
patterned surface.120 Because the surface of PDMS stamps is inherently hydrophobic, this 
method is best suited to transfer small non-polar molecules. In order to employ PDMS 
stamps for patterning hydrophilic materials, the surface of the stamp must be rendered 
hydrophilic.130 Although several techniques have been developed to render the PDMS 
surface hydrophilic, these stamps are still not ideal for patterning hydrophilic materials 
such as proteins. In 1998, Martin et al. have introduced the concept of a “hydrogel 
stamper” as an alternative to PDMS stamps for stamping hydrophilic materials.130 
Hydrogels are hydrophilic polymers; stamps made of these polymers often contain more 
than 90% water.130-133 In addition, hydrogel stamps are porous and can provide a hydrated 
and biocompatible reservoir for biomolecules.130-133 These characteristics make hydrogel 
stamps ideal for patterning biomolecules. Hydrogel stamps have been employed to 
pattern a variety of soluble proteins (e.g. antibodies and cell adhesion factors)130,131 as 
well as bacterial133 and mammalian cells.132 Hydrogel stamps have also been used for 
controlled etching134 and reactive-patterning of solid surfaces.135  
Here we present the first attempt to use hydrogel stamps to create arrays of fluid 
and functional membranes with and without integral membrane proteins for screening of 
membrane interactions within chapters 5 and 6. 
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Chapter 2  
Gramicidin Pores Report the Activity of Membrane-Active Enzymes 
 
 Abstract 
Phospholipases constitute a ubiquitous class of membrane-active enzymes that 
play a key role in signaling, proliferation, and membrane trafficking. Aberrant 
phospholipase activity is implicated in a range of diseases including cancer, 
inflammation, and myocardial disease. Characterization of these enzymes is therefore 
important, both for improving the understanding of phospholipase catalysis, and for 
accelerating pharmaceutical and biotechnological applications. This chapter describes a 
novel approach to monitor, in-situ and in real-time, the activity of phospholipase D 
(PLD) and phospholipase C (PLC) on planar lipid bilayers. This method is based on 
enzyme-induced changes in the electrical charge of lipid bilayers and on the concomitant 
change in ion concentration near lipid membranes. The approach reports these changes in 
local ion concentration by a measurable change in the ion conductance through pores of 
the ion channel-forming peptide gramicidin A. This enzyme assay hence takes advantage 
of the amplification characteristics of gramicidin pores to sense the activity of picomolar 
to nanomolar concentrations of enzyme without requiring labeling of substrates or 
products. The resulting method proceeds without the need for detergents, quantifies 
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enzyme activity on native lipid substrates within minutes, and provides unique access to 
both leaflets of well-defined lipid bilayers; this method also makes it possible to generate 
planar lipid bilayers with transverse lipid asymmetry. 
 
2.1. Introduction 
Phospholipases are membrane-active enzymes that catalyze the hydrolysis of 
specific ester bonds in phospholipids. These enzymes play a critical role in cell signaling, 
proliferation, and vesicle trafficking.1-3 As a result, phospholipases are implicated in a 
range of diseases including cancer, inflammation, and myocardial disease.1-4 To improve 
the understanding of these enzymes, characterization methods that monitor the activity of 
phospholipases in situ, in real time, and in a label-free fashion, would be useful. Due to 
the heterogeneous nature of catalytic reactions on lipid membranes it is, however, often 
challenging to monitor the activity of membrane-active enzymes.5-7 Established methods 
to characterize phospholipases include pH-stat5,8-10 and those assays that measure the 
absorbance,7,8 fluorescence,9,11 or radioactivity3,7,12 of their enzymatic products. While 
radioactive and fluorescent assays offer high sensitivity, these assays are often not 
performed in situ, and the need for labeling of the substrate can limit the application or 
affect the results of these assays. Other assays employ coupled enzyme reactions1,13,14 in 
which the optimum experimental condition may be limited by the second enzyme. More 
recently, liquid crystals were employed for label-free detection of phospholipase activity, 
however, this approach is not quantitative.15,16 
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Here, we describe a novel, label-free, rapid, and quantitative method to monitor, 
in situ, the activity of phospholipases D and C (PLD, PLC) on planar lipid bilayers. This 
approach offers high sensitivity by ion channel amplification17-21 and employs planar 
lipid bilayers instead of micelles or liposomes. The assay hence provides access to both 
leaflets of a bilayer—a unique characteristic that makes this assay platform attractive for 
generating asymmetric lipid bilayers by adding different enzymes to each side of a 
membrane.  
PLD cleaves the phosphodiester bond on the polar side of phospholipid 








Figure 2-1. In situ monitoring of the activity of PLD on planar lipid bilayers by changes in single 
channel conductance of gA pores, γ. (a) As PLD hydrolyzes electrically neutral (zwitterionic) 
phosphatidylcholine (PC) lipids and produces choline and negatively-charged phosphatidic acid 
(PA) lipids,1 accumulation of cations close to the membrane surface leads to a significant increase 
in γ.18,22,23 (b) Current versus time recordings in the presence of 2 pM gA before and after addition 
of PLD. Current steps in these recordings represent opening and closing of individual gA pores. 
(c) Corresponding histograms of current amplitudes illustrate the PLD-induced increase in the 
mean step amplitude of currents through individual gA pores: 0.36 pA before addition of PLD 
(left panel) compared to 0.96 pA after addition of PLD (right panel). Dividing this amplitude by 
the voltage that was applied during the current recording (here 0.1 V), revealed γ = 3.6 pS before 











Figure 2-2. PI-PLC catalyzed hydrolysis of PI lipids proceeds in two steps. In the first reaction, 
PI-PLC catalyzes hydrolysis of PI to produce electrically neutral DAG lipids and soluble myo-
inositol 1,2-cyclic phosphate and in the second, slower reaction PI-PLC hydrolyzes myo-inositol 
1,2-cyclic phosphate to myo-inositol 1-phosphate.12,24   
 
These phospholipases, therefore, modify the headgroup of phospholipids and, for 
many lipid substrates, this modification results in a change in the net charge of the lipid 
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molecule. At ionic strengths close to, or below the physiologic range, this enzyme-
induced change in the electric charge on the lipids in a membrane results in a change of 
the local concentration of counter ions near the membrane surface25 and can be detected 
by the channel-forming peptide gramicidin A (gA).18,22,23,26 Hence, the enzyme assays 
introduced here, take advantage of the change in the single-channel ion conductance 
through gA pores, γ, in response to enzyme-catalyzed modifications of the charge of 
lipids.18,22,23 Figure 2-1 illustrates this concept for PLD. 
 
2.2. Results and Discussion 
2.2.1. PLD Assay 
In order to demonstrate the ability of this gA-based assay to detect the enzymatic 
activity of PLD, we formed planar lipid bilayers containing phosphatidylcholine (PC) 
lipids as substrate and monitored the changes in γ upon addition of PLD from cabbage 
(EC 3.1.4.4).27 To relate the changes in γ to the changes in membrane composition, we 
first acquired a calibration curve (Figure 2-3a) of γ (in units of pS = 10-12 Ω-1) as a 
function of the mole fraction of phosphatidic acid (XPA, unitless); PA is the negatively-
charged lipid product of PLD-catalyzed hydrolysis of neutral PC lipids (Figure 2-1a). Eq. 
(1), which resulted from the curve fit in Figure 2-3a, describes this calibration curve:27 
 
3.50 pS (12.83 pS ) / (0.23 ) .PA PAX Xγ = + × +       (1)    
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Figure 2-3b demonstrates that the addition of PLD to both sides of a bilayer 
resulted in a time-dependent increase in γ. Interestingly, this increase progressed with an 
initial lag phase of slow change, followed by a rapid increase in γ. We attributed this lag 
phase (which lasted 5-9 min depending on the enzyme concentration) to a mixing time 
and delayed binding of PLD to PC membranes. Kuppe et al. have previously reported a 
similar lag phase of slow activity of PLD on PC bilayers. These authors demonstrated 
that Ca+-induced formation of PA domains in PC membranes27 is a key parameter that 
facilitates binding of PLD to the membrane surface and significantly increases the 
hydrolysis rate of PLD.14  
To estimate the change in XPA in membranes upon addition of PLD, we used 
Eq. (1). Figure 2-4 shows the linear, time-dependent changes in XPA after the lag phase 
for different PLD concentrations. We defined the lag time as the interval from addition of 
PLD until XPA reached a value of ~0.03. The inset in Figure 2-4 reveals that the rate of 














Figure 2-3. Single channel conductance of gA pores, γ, as a function of PA membrane content 
and as a function of time after addition of PLD. (a) Calibration curve of γ versus the mole fraction 
of negatively-charged PA lipids, XPA, in PC membranes. The graph shows the best fit (R2 = 0.97, 
N = 7) to a hyperbolic function27 of the form γ = γ0 + (A × XPA) / (B + XPA), where A (pS) and B 
(unitless) are fitting parameters, and γ0 (pS) is γ before the addition of PLD. (b) Time-dependent 
increase in γ upon addition of various conc. of PLD, including: (■) 2.3, (●) 3.1, and (▼) 5.2 
units·mL-1 corresponding to PLD conc. of ~15-40 nM to a pure PC bilayer. The lines represent 
the best linear fits. For each PLD concentration, points within the lag phase and after the lag 
phase were fitted separately. Typically the slope after the lag phase was 2.6-3.1 fold larger than 
the slope during the lag phase. The inset shows the enzymatic hydrolysis by 4.2 units·mL-1 of 
PLD over an extended period of time. Error bars represent the standard error of the mean (N  ≥ 3). 
Ion channel recordings proceeded in an aqueous electrolyte containing 10 mM CsCl, 0.5 mM 
CaCl2, and 10 mM cesium acetate at pH 5.5.  
 




Figure 2-4. Graph showing the change in mole fraction of PA, XPA, in PC membranes after 
addition of (■) 2.3, (●) 4.2, and (▼) 5.2 units·mL-1 PLD. The x-axis shows the time after the lag 
phase. The lines represent the best linear fits to the data. Error bars represent the standard error of 
the mean (N ≥ 3). The inset depicts the slope from these linear fits, representing dXPA/dt as a 
function of PLD concentration. Error bars in the inset show the error of the linear fits used to 
obtain dXPA/dt.   
 
2.2.2. Lag Phase in PLD Hydrolysis  
Figure 2-5, which shows a plot of XPA as a function of time, illustrates a clear 
biphasic behavior with two distinct linear slopes. In the first phase, defined as lag phase 
(the time interval from addition of PLD until XPA reached a value of ~0.03), which started 
immediately after addition of PLD and typically continued for ~5-9 min, XPA increased 
slowly with time in a linear fashion. Once the mole fraction of PA reached a value of 
~0.03, the time-dependent increase of XPA entered a second phase of linear change with a 
steeper positive slope. In the analysis performed here, we employed the linear slope of 
the second phase as the initial hydrolysis rate of PLD (Figure 2-4). The hydrolysis rate 
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after the lag phase was typically 3-6 fold higher than the hydrolysis rate during the lag 
phase.  
 
Figure 2-5. Biphasic change in mole fraction of PA, XPA, in PC membranes after addition of (■) 
2.3 (●) 4.2, and (▼) 5.2 units·mL-1 PLD. The graph shows the mean value of XPA in planar lipid 
bilayers after addition of PLD. Error bars represent the standard error of the mean (N ≥ 3). 
Dashed lines represent the best linear fits to the data (black:   XPA = -0.009 + 0.006 (min-1) × t 
(min), with N = 8, R2 = 0.86, red: XPA = -0.031 + 0.017 (min-1) × t (min), with N = 8, R2 = 0.91, 
blue: XPA = -0.045 + 0.025 (min-1) × t (min), with N = 6, R2 = 0.87). The first part of the solid 
lines represents the best linear fits  to the points in the lag phase (black: XPA = 0.006 + 0.003 
(min-1) × t (min), with N = 4, R2 = 0.85, red: XPA = 0 + 0.006 (min-1) × t (min), with N = 3, R2 = 
1, blue: XPA = 0.005 + 0.006 (min-1) × t (min), with N = 3, R2 = 0.78) and the second part of the 
solid lines represent the best linear fits to the points after the lag phase (black: XPA = -0.061 + 
0.009 (min-1) × t (min), with N = 4, R2 = 0.99, red: XPA = -0.086 + 0.022 (min-1) × t (min), with 
N = 6, R2 = 0.96, blue: XPA = -0.142 + 0.034 (min-1) × t (min), with N = 4, R2 = 0.93). The gray 




2.2.3. Control Experiments 
To confirm a functional dependence of γ on the enzymatic activity of PLD, we 
performed a control experiment with heat-denatured PLD and found no increase in γ 
(Figure 2-6a). Furthermore we monitored the changes in γ upon addition of PLD in the 
presence of two PLD inhibitors, resveratrol3,28 and cyclosporine A.29 Figure 2-6a shows 




Figure 2-6. (a) Comparison of the initial velocity (dXPA/dt) of PC hydrolysis by 4.2 units·mL-1 of 
PLD in the presence of two inhibitors, resveratrol (final conc. ~130 μM) and cyclosporin A (final 
conc. 5 μM), and after adding heat-denatured PLD. All error bars show the error of the linear fits 
used to obtain dXPA/dt. (b) Effect of PA content in planar lipid bilayers on the conductivity 
through the bilayer in the absence of gA. Error bars represent standard error of the mean (N ≥ 3).  
 
We also examined the effect of the soluble product of the reaction, choline, on γ. 
During the experiments with PLD, the mole fraction of the enzymatic product PA 
a)                                                       b)
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typically reached a final value of ~0.3 which corresponded to ~45 nanomoles of PA lipids 
and an average concentration of ~15 μM in a 3 mL compartment. We, therefore, 
estimated the concentration of the soluble product of this enzymatic reaction, choline, to 
be ≤ 15 μM and examined the effect of choline chloride on the conductance of gA within 
a final concentration range of 0-20 μM (in a buffer solution containing 10 mM CsCl and 
10 mM cesium acetate with a pH of 5.5). These experiments revealed that the presence of 
0-20 µM choline chloride did not significantly affect the single channel conductance of 
gA (change < 3%). 
Hovis and co-workers have investigated the effect of ionic strength on the 
organization and topology of supported lipid bilayers composed of PC and PA lipids.30,31 
These authors demonstrated that lowering the ionic strength led to formation of PA-
enriched domains in supported bilayers that contained more than 10 mol% PA. To 
examine the effect of such organizational change on the permeability of the planar lipid 
bilayers employed in this work, we probed the conductivity through PC bilayers that 
contained 0-30 mol% of PA lipids under the same condition as the enzymatic assay but in 
the absence of gramicidin pores. Figure 2-6b illustrates the mean conductance through 
the examined lipid bilayers with different PA contents but in the absence of gA. These 
results revealed small variations in conductance of these lipid bilayers (0.3-0.4 pS), 
however, we did not observe a trend of the change in conductance as a function of XPA. 
As explained before, these small variations in conductance of ions through the bilayer 
membrane itself, did not affect the accuracy of the determination of the single channel 
conductance of gA pores since we based the analysis exclusively on step-changes in 
current which resulted from opening and closing of individual gA pores. 
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Together, these control experiments confirmed that the increase in γ upon addition 
of PLD was due to enzymatic activity and not due to artifacts. 
 
2.2.4. Generation of Asymmetric Lipid Bilayers 
To explore the potential of this assay platform to create asymmetric planar lipid 
bilayers, we exposed one side of a PC bilayer to active PLD and the other side to 
inactivated PLD. We hypothesized that asymmetric activity of the enzyme would create a 
planar bilayer with transverse asymmetry, in which one leaflet (exposed to active PLD) 
would contain the catalytic product, i.e. negatively-charged PA lipids, and the other 
leaflet (exposed to inactivated PLD) would retain unmodified substrate, i.e. neutral PC 
lipids. We have previously demonstrated that γ  is affected only by the electric charges 
present near the entrance of gA channels and not by the charges near the exit of the 
pore.18 Since gA is permeable to cations, the entrance of gA pores is always located in the 
positively polarized compartment of the bilayer setup. Hence, the entrance of gA 
channels can be switched from one compartment to the other based on the polarity of 
applied voltage. We, therefore, hypothesized that if asymmetric activity of PLD on the 
PC bilayer produces a bilayer with transverse lipid asymmetry, gA pores would have a 
large conductance when the polarity of the voltage would place the entrance of gA on the 
side of the negatively-charged leaflet (i.e., the side with active PLD), whereas gA pores 
would have a low conductance when the polarity of the voltage would place the entrance 
on the side of the neutral leaflet of the bilayer (i.e., the side with inactive PLD).   
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Figure 2-7b shows that, as expected, γ changed asymmetrically depending on the 
polarity of the applied voltage: at +100 mV, γ increased over time (with this polarity, the 
entrance of the gA pores was located on the side with active PLD), whereas γ did not 
increase significantly at -100 mV, when the polarity placed the gA entrance on the side 
with inactive PLD. We obtained inactivated PLD from a preparation that went through at 




Figure 2-7. Generation of planar lipid bilayers with transverse asymmetry by addition of active 
PLD to one compartment of the bilayer setup and addition of inactive PLD to the other 
compartment. (a) Schematic representation of PLD-induced asymmetry in a bilayer. (b) Graph 
showing changes in γ when the polarity was such that (●) the entrance of gA pores was located in 
the compartment with 4.2 units·mL-1 active PLD, or (■) in the compartment with 4.2 units·mL-1 
inactive PLD. Error bars represent the standard error of the mean (N ≥ 3). The solid red curve 
illustrates the best fit (R2 = 0.93, N = 6) of the points shown in red to Eq. (3). For this fit only data 
after the lag phase were included (the point at ~5 min corresponds to XPA ~0.03 and marks the end 
of lag phase). 
a)                                         b) 
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To describe the relationship between γ and the time after addition of PLD, we 
derived an equation to fit the data in Figure 2-7b. As shown by Eq. (1), γ is a hyperbolic 
function of the mole fraction of PA in the membrane, XPA, while the relationship between 
XPA and time, t, after addition of PLD can be described by a rate equation for pseudo-first 
order kinetics of the form:  
 
1  ,ktPAX e
−= −          (2)                                
 
where the fitting parameter k (min-1) is a pseudo-first order rate constant of the overall 
reaction at a given concentration of PLD. Combining Eq. (1) and Eq. (2), we obtained the 



















       (3)                                
                                                                                                                                                            
We introduced t0 (min) in Eq. (3) to account for the lag phase. The solid red curve in 
Figure 2-7 illustrates the best fit of the six points shown in red after the lag phase to Eq. 
(3), with k = 0.02 min-1 and t0 = 3.16 min for the best fit. 
The strong difference between γ as a function of the polarity of the applied voltage 
in Figure 2-7b demonstrates the ability of the platform presented here to create 
asymmetric lipid bilayers by asymmetric addition of an enzyme to a symmetric planar 
bilayer. Although not demonstrated in this communication, we think that this capability is 
attractive since intracellular lipases process lipids in natural biomembranes with strong 
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transverse asymmetry. The assay developed here, may hence make it possible to study 
lipase activity in bilayers that are better models of physiologic membranes than 
liposomes or micelles. In addition, the capability of generating asymmetric lipid bilayers 
by exploiting lipase activity as demonstrated here, may be useful for studying the effect 
of transverse asymmetry on the activity of other membrane proteins, such as ion channels 
and transport proteins. And finally, the results from asymmetric addition of enzymes 
shown in Figure 2-7, provide additional evidence that the observed changes in γ were 
indeed due to the enzyme activity of phospholipase and not due to artifacts. 
 
2.2.5. PLC Assay 
In order to extend this label-free, ion channel-based approach of quantifying 
enzyme activity to another relevant enzyme, we monitored the activity of 
phosphatidylinositol-specific PLC (PI-PLC) from Bacillus cereus (EC 3.1.4.10). In this 
case, we recorded the changes in γ in PC bilayers that contained initially 10 % PI (i.e. 
XPI,0 = 0.1) upon addition of the PI-PLC enzyme. 
In these experiments, as PI-PLC catalyzed the hydrolysis of negatively-charged PI 
lipids and produced neutral diacylglycerol (DAG) lipids12 (Figure 2-2), the concentration 
of cations close to the membrane surface gradually decreased, leading to a measurable 
reduction of γ. Figure 2-8a shows a calibration curve of γ as a function of XPI. Eq. (4), 
which resulted from the curve fit in Figure 2-8a, describes this calibration curve: 
 












Using Eq. (4), we estimated XPI as a function of time after addition of PI-PLC. 
Figure 2-8b shows the decrease in XPI after addition of ~40 and ~80 pM of PI-PLC. The 
initial slopes of the two resulting exponential fits in Figure 2-8a, differed by a factor of 




Figure 2-8. (a) Single channel conductance of gA, γ, as a function of the mole fraction of PI (XPI) 
in PC membranes. The black curve corresponds to Eq. (4) and represents the best fit (R2= 0.93, 
N = 5) to a hyperbolic function. (b) Decrease in XPI of membranes after addition of (●) 0.0015 and 
(■) 0.0030 units·mL-1 PLC. The solid curves show the best fit of the data to an exponential decay 
of the form XPI  = XPI,0 × exp (-k × t), where XPI,0 = 0.1, while k (min-1) is the fitting parameter at a 
given enzyme concentration, and t (min) is time. All error bars represent the standard error of the 
mean (N ≥ 3). Single channel recordings proceeded in 20 mM KCl with 10 mM HEPES at pH 
7.4.  
b) a)                                             
58 
 
2.2.6. Limit of Detection and Sensitivity of the Assay 
The limit of detection (LOD) of the PLD assay and the PLC assay presented here, 
according to the definition of LOD = 3 × standard deviation (STD), is equal to a mole 
fraction of PA, XPA, of 0.003 and to a mole fraction of PI, XPI, of 0.078 respectively. We 
calculated the LOD for the PLD enzymatic assay considering a standard deviation of 0.05 
pS for the conductance of gA in a PC bilayer. For this analysis, we employed Eq. (1) and 
standard error propagation rules to convert the smallest detectable change in the 
conductance of gA, γ, to the smallest detectable change in XPA in the membrane as the 
detection limit of this assay. A similar approach for the PLC enzymatic assay, 
considering a standard deviation of 1.45 pS for the conductance of gA in a bilayer 
composed of PC and 10 mol% PI and employing Eq. (4) gave a value of 0.078 as the 
smallest detectable change in XPI in the membrane as the detection limit of this assay. 
We obtained this sensitivity with an ionic strength of ~21.5 mM; the sensitivity of 
the assay decreases with increasing ionic strength because the effect of electrostatic 
attraction of cations near a negatively-charged membrane surface will contribute 
relatively less to γ than the increased concentration of cations in the bulk solution.18,22,23,27 
Nevertheless, we and others showed previously that negatively-charged membranes still 





2.2.7. Signal Amplification through Gramicidin A Pore 
Ion channels are attractive for sensing applications due to their inherent 
amplification capability:15,18,20-23,32-38 Opening of a single ion channel can lead to the flux 
of 103-106 ions per millisecond through the channel.18 Previous studies have employed 
gA pores26,39-45 to sense the electrical charge on the lipids surrounding the channel in the 
membrane.18,22,23 These studies showed that a slight difference in the electrical charge on 
the lipid membrane can lead to an amplified change in single channel conductance of gA. 
The present assay took advantage of this amplifying effect of gA pores to detect the 
enzymatic activity of PLD and PLC. For instance, Figure 2-3a reveals that an increase of 
only 5% in the mole fraction of negatively-charged PA lipids in a PC membrane (i.e., a 
change from XPA = 0 to XPA = 0.05) led to an increase in single channel conductance of gA 
pores from γ = 3.5 pS to γ = 6.5 pS, corresponding to an increase of 86%. In this assay, 
therefore, gA pores offered an amplification factor of ~17 (0.86 / 0.05) for sensing the 
enzymatic activity of PLD.  
 
2.3. Conclusion 
In summary, this work presents a novel, label-free assay to monitor, in real time, 
the enzymatic activity of phospholipases D and C on planar lipid bilayers. This ion 
channel-based assay provides unique access to both leaflets of a bilayer, proceeds on 
membranes with well-defined lipid composition, and exploits  amplification 
characteristics of an ion pore.18 In addition, this assay detects enzyme activity within 
minutes at picomolar to nanomolar concentrations of enzyme on native lipid substrates 
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without requiring detergents or labels. Finally, this assay platform makes it possible to 
generate planar lipid bilayers with transverse lipid asymmetry.  
 
2.4. Experimental Section  
2.4.1. Materials  
We purchased cesium acetate, resveratrol, and cyclosporin A from Sigma Aldrich; 
potassium chloride (KCl) from EMD Chemicals; cesium chloride (CsCl) from 
International Biotechnologies, Inc.; choline chloride from Fluka; calcium chloride 
(CaCl2), pentane, and  hexadecane from Fluka; and HEPES from Fisher Scientific. 
Gramicidin A (gA) was purchased as gramicidin D from Sigma Aldrich and purified by 
silica chromatography as described previously46 to afford a final purity of 97% of gA. We 
purchased the following phospholipids form Avanti Polar Lipids, Inc.: 1,2-diphytanoyl-
sn-glycero-3-phosphocholine (DiPhyPC), 1,2-diphytanoyl-sn-glycero-3-phosphate 
(sodium salt) (DiPhyPA), and 1,2-dioleoyl-sn-glycero-3-phosphoinositol (ammonium 
salt) (PI). Phospholipase D (PLD) from cabbage (EC 3.1.4.4) was obtained from Sigma 
Aldrich and phosphatidylinositol-specific phospholipase C (PI-PLC) from Bacillus 
cereus (EC 3.1.4.10) was purchased from Invitrogen.  
 
2.4.2. Storage and Final Concentration of Enzymes 
We received PLD as a lyophilized powder and immediately dissolved it in a 
buffer solution containing 10 mM CsCl, 0.5 mM CaCl2, and 10 mM cesium acetate with 
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a pH of 5.5 (the same buffer was used for single channel recordings with this enzyme) to 
a final activity of 2,500 units mL-1. We aliquoted and stored this PLD solution at -
80º C until usage. According to Sigma Aldrich, one unit of PLD liberates 1.0 μmol of 
choline from L-α-phosphatidylcholine (egg yolk) per hour at pH 5.6 at 30 °C. The 
specific activity of this enzyme, provided by Sigma Aldrich, was more than 1670 units 
per milligram of protein. Assuming a pure enzyme and considering a molecular weight of 
~92,000 Da,47 a concentration of 1 unit mL-1 corresponds to a concentration of ~17.1 nM. 
We used this enzyme in a concentration range of ~15-40 nM in the bilayer chamber. 
We received PI-PLC with an activity of 100 units mL-1 in a solution containing 20 
mM Tris-HCl, pH 7.5, 1 mM EDTA, 0.01 % sodium azide, and 50% glycerol from 
Invitrogen, and stored it at -80º C. After thawing this enzyme preparation for the first 
time, we diluted it 10-fold in a buffer solution containing 20 mM KCl, 10 mM HEPES, 
pH 7.4 (this buffer was used for single channel recordings with this enzyme). We then 
aliquoted and stored the diluted enzyme solution at -80º C until usage. The unit definition 
for this enzyme, according to Invitrogen, is the amount of enzyme that converts 1 μmol of 
substrate to product per minute under the conditions of the assay. The specific activity of 
this enzyme, according to Invitrogen, was at least 1,000 units per milligram of protein. 
Assuming a pure enzyme and considering a molecular weight of ~35,000 Da, a 
concentration of 1 unit mL-1 corresponds to ~10.9 nM. We used this enzyme in a 
concentration range of ~43-86 pM in the bilayer setup. Therefore, with the standard 
bilayer setup used here, which had a volume of 3-4 mL, we were able to sense the 
activity of 172 femtomoles of PLC enzyme. It may be worth to point out that 
microfabricated bilayer setups48-51 have the capacity of measuring single ion channel 
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conductance in volumes as small as 10 μL. Employing such miniaturized setups for the 
assays developed here, may make it possible to quantify the activity of 430 attomoles of 
PLC. 
To minimize loss of enzyme activity due to storage of these enzymes in solution, 
we always thawed fresh aliquots of enzyme solutions shortly before addition to the 
bilayer setup. 
 
2.4.3. Formation of Planar Lipid Bilayers 
We formed planar lipid bilayers52,53 with the “folding technique”18,32 in a custom-
made bilayer setup fabricated in Teflon with two compartments of 3 or 4 mL capacity. 
We separated these two compartments by a thin Teflon film that contained one aperture 
with a diameter of ~100 μm (Eastern Scientific Inc.). We used vacuum grease (Corning) 
to attach the Teflon film to the chamber and to create a water tight seal between the two 
compartments. To facilitate bilayer formation, we pretreated the area surrounding the 
aperture of the Teflon film on each side with 2 μL of 5% (v/v) hexadecane in pentane. 
After addition of 1 mL of appropriate electrolyte (see below) to each compartment, we 
spread 3-5 µL of a lipid solution in pentane (25 mg mL-1 for DiPhyPC or 5 mg mL-1 for 
mixtures containing 90 mol% DiphyPC and 10 mol% phosphatidylinositol) at the air-
water interface of the electrolyte solution and raised the liquid level by adding another 2 
or 3 mL (depending on the compartment size) of electrolyte. Raising the liquid level in 
these two compartments above the aperture in the Teflon film resulted in the formation of 
a lipid bilayer from apposition of two lipid monolayers as described originally by Montal 
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and Mueller54. If raising the liquid level did not immediately result in formation a bilayer 
over the aperture, we lowered the liquid level in one or both compartments, followed by 
raising the electrolyte solution again. We repeated this cycle until we obtained a bilayer 
with a minimum capacitance of 70 pF. 
The electrolyte solution for the experiments with PLD contained 10 mM CsCl, 0.5 
mM CaCl2, and 10 mM cesium acetate at a pH of 5.5 (adjusted with HCl). For 
experiments with PLC, the electrolyte contained 20 mM KCl and 10 mM HEPES at a pH 
of 7.4 (adjusted with KOH). We chose electrolytes with low ionic strength for these 
single channel recordings because the charge-induced local increase in cation 
concentration close to a membrane affects the gA conductance more significantly under 
conditions of low ionic strength compared to conditions of high ionic strength.18,22,23 
 
2.4.4. Single Channel Recordings   
Once a stable lipid bilayer was obtained, we gradually added small volumes (0.1 
µL) of a solution of 10 ng mL-1 gA in isopropanol (Acros Organics) to both 
compartments of the bilayer setup until one to six gA channels were inserted in the 
bilayer at the same time. We chose isopropanol as solvent for gA since tertiary alcohols 
are not substrates for PLD as opposed to primary and secondary alcohols. After each 
addition of gA, we mixed the bilayer chambers by stirring the solutions in both 
compartments for at least 3 min (we confirmed previously that a small droplet of food 
dye was completely mixed in the setup within 2 min of stirring). In these experiments the 
final concentration of gA in the bilayer chamber was in the range of 0.1-2.0 pM. This 
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range of gA concentration corresponds to 0.3-8 femtomoles of gA in the chamber with a 
volume of 3-4 mL; the total amount of lipid in each compartment was ~150 nanomoles, 
leading to a lipid to gA ratio of ~108. To measure the single channel conductance of gA 
pores,55-59 we recorded current traces versus time while applying different voltages in the 
range of ±100 mV. We performed these single channel recordings in “voltage clamp 
mode” using Ag/AgCl pellet electrodes (Warner Instruments) in both compartments of 
the bilayer setup. Data acquisition and storage was carried out using a custom software 
written in Labview by Daniel J. Estes in combination with a Geneclamp 500 amplifier 
from Axon Instruments (set to a gain of 100 mV pA-1 and a filter cutoff frequency of 2 
kHz). The data acquisition board (National Instruments) that was connected to the 
amplifier was set to a sampling frequency of 15 kHz. All recordings were carried out at a 
temperature of ~22º C.  
We performed the analysis of the single channel current traces by computing 
histograms of the currents from the original current versus time traces with Clampfit 9.2 
software (Axon Instruments). From these histograms, we extracted the mean current 
amplitude of gA channel opening and closing events. All conductance values were 
obtained from the slopes of current amplitudes versus voltage (I-V) curves (see the next 
section for more details on this analysis).  
In order to reduce the noise in these single channel recordings, we mounted the 
bilayer setup on a low noise stir plate (Stir-2, Warner Instruments), which was placed on 
a bench top vibration isolation platform (50 BM-4, Minus K Technology) inside a 
Faraday cage from Warner Instruments. In addition, we found that we reached the 
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minimum noise level by placing the aforementioned setup on top of a second vibration 
isolation table (63-500 series from TMC) with a Faraday cage. 
 
2.4.5. Monitoring Changes in gA Conductance Induced by Enzymatic Activity and 
Statistical Data Analysis 
Upon addition of enzyme to a bilayer that contained gA pores, we recorded short 
(≤ 60 s) current traces at different applied voltages and at distinct points of time (Figure 
2-9). To analyze these current versus time traces, we first obtained a histogram that 
represented the distribution of currents for each current trace (Figure 2-9). The difference 
in current between adjacent peaks in these histograms represented the current amplitude 
of single gA channel openings. These current amplitudes, therefore, reflect the single 
channel conductance of gA, γ, at a given time after addition of PLD. By averaging all 
current amplitudes within a histogram, we obtained the mean current amplitude of gA 
events and a standard deviation (STD) for this mean for each trace for a given time after 
addition of the enzyme. We plotted these mean current amplitudes as a function of the 
applied voltage for each time point. We obtained a mean value for single channel 
conductance of gA, γ, at a given time point from the slope of the resulting current versus 
voltage (I-V) curve in the linear range ≤ |± 100 mV| of the curve. 
As demonstrated in Figure 2-9, the current amplitude of gA opening and closing 
events increased over time after addition of PLD to the bilayer setup. These results were 
further confirmed by Figure 2-10 which illustrates the distribution of current amplitudes 
of gA events in a time-dependent manner after addition of PLD to a PC bilayer. In this 
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figure, a clear shift in the mean current amplitude of gA events reflects a PLD-induced 




Figure 2-9. Current versus time recordings in a lipid bilayer that contained gA channels (a) 
before addition of PLD and (b) 5 min, and (c) 13 min after addition of PLD (with a final 
concentration of 3.1 units·mL-1). Each step increase in current represents the formation of one gA 
channel and each step decrease represents the dissociation of one gA channel.  The corresponding 
histograms on the right illustrate the distribution of current in each trace. The difference in current 
between adjacent peaks in these histograms reflects the current amplitude of step-wise gA events. 











Figure 2-10. Distribution of current amplitudes of gA events at differnt time points after addition 
of 3.1 units·mL-1 PLD to a PC bilayer. Histograms of current amplitudes of individual gA 
opening and closing events (a) before addition of PLD, (b) 5 min, (c) 7 min, and (d) 13 min after 
addition of PLD. Ion channel recordings proceeded in an electrolyte solution containing 10 mM 
CsCl, 0.5 mM CaCl2, and 10 mM cesium acetate at pH 5.5.    
a)          
b)          
c)          
d)          
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Figure 2-11 shows the statistical distribution of current amplitude of gA channels 
in PC bilayers as a function of the mole fraction of the negatively-charged lipid, PA. 
These results illustrate the effect of PA lipids in the bilayer on single channel 
conductance of gA pores and, in combination with the control experiments presented in 
the main text, confirm that the increase in gA conductance after addition of PLD is a 
result of the enzymatic activity of PLD that produces negatively-charged PA lipids. 
These results also confirm that at low mole fraction of PA (XPA ≤ 0.1) differences in mole 
fraction of 0.003 could be detected according to a limit of detection, defined as 






Figure 2-11. Distribution of current amplitudes of gA events in electrically neutral PC bilayers 
with different contents of negatively-charged PA lipids. (a) Histograms of current amplitudes of 
gA events in PC bilayers that contained 0, 10, and 30 mol% PA lipids. (b) Box chart showing the 
distribution of current amplitudes of gA events in these bilayers. Boxes represent the median ± 
standard deviation (STD). Error bars represent the minimum and maximum current amplitudes. 
Ion channel recordings proceeded in an electrolyte solution containg 10 mM CsCl, 0.5 mM 
CaCl2, and 10 mM cesium acetate at pH 5.5.    
 






2.4.6. Cleaning of the Planar Lipid Bilayer Setup 
In order to ensure recordings from high quality bilayers without contaminations 
from previous experiments, we cleaned the bilayer chamber and setup in the following 
way: We removed the Teflon film that was previously mounted by vacuum grease to 
separate two compartments of the bilayer setup, and we cleaned the film by several 
washes with a stream of chloroform from a Teflon squirt bottle, followed by air drying 
before storage. Second, we rinsed the chamber with deionized water, followed by 
ethanol, and finally by chloroform. After two chloroform rinses, we used a Kimwipe 
tissue to clean the inside walls of the chamber such that all the vacuum grease was 
removed, and we, again, rinsed the chamber with chloroform. We stored the chamber in 
chloroform between experiments. 
Note, all steps with solvents (in particular chloroform) were carried out in a chemical 
fume hood.    
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Chapter 3  
Kinetic Parameters of Heterogeneous Catalysis of Phosphatidylcholine 
by Phospholipase D  
 
Abstract 
The enzymatic reaction of interfacial enzymes is an important example of 
heterogeneous catalysis. Describing the kinetics of these reactions is, hence, a difficult 
task and requires further theoretical advancements. This chapter presents an attempt to 
describe the kinetics of the enzymatic reaction of phospholipase D (PLD) using the 
quantitative results of the gramicidin-based PLD assay introduced previously. We present 
an adaptation of a basic kinetic model for interfacial reactions to the PLD assay presented 
in this thesis. Employing this model, we estimated the kinetic parameters of the 




Phospholipases form a group of interfacial enzymes that catalyze the hydrolysis 
of the ester bonds in phospholipids and play an important role in lipid metabolism.1-4 
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While these enzymes are water soluble, their substrates (i.e. phospholipids) are 
water insoluble. Enzymatic reactions of these enzymes, therefore, depend strongly on the 
organization of phospholipids in interfacial structures such as liposomes or micelles.1  
The underlying variables in a microscopically heterogeneous environment are far 
more complex than those encountered by a soluble enzyme in a homogeneous solution.1-
3,5 Enzymatic reactions of interfacial enzymes, therefore, present an important example of 
heterogeneous catalysis. 
Within the past fourty years, several kinetic models have been developed to 
describe the enzymatic reaction of interfacial enzymes. Verger et al. have proposed the 
first and simplest kinetic model in which the Michaelis-Menten chemical step and the 
interfacial activation of the enzyme are combined.6 Since then, various kinetic models 
were proposed for various interfacial structures including lipid monolayers, liposomes, 
micelles, and oil in water emulsions.3,5,7,8 Examples of these models are the “surface 
dilution kinetics” that describes catalysis on mixed micelles3,7,9 and the “scooting and 
hopping modes” of enzyme action that describes catalysis on liposomes.5,8       
In the previous chapter, we presented the first assay for phospholipases D and C 
that is based on planar lipid bilayer systems. In this chapter, we adopt a basic kinetic 
model for interfacial hydrolysis6 and apply this model to the assay introduced here. The 





3.2. Kinetic Model 
Figure 3-1 illustrates the schematic representation of the simplest adaptation of 
the Michaelis-Menten model to the interfacial hydrolysis of lipids that was proposed by 
Verger. et al.6 In this model, the first step is the adsorption of a water-soluble enzyme, E, 
to the lipid-water interface. This step leads to a more energetically-favorable state, E*, for 
binding to the substrate compared to the enzyme in the aqueous phase, E. This step is 
followed by a two-dimensional Michaelis-Menten catalytic step. The enzyme at the 
interface, E*, binds a substrate molecule, S, to form the E*S complex, followed by its 
decomposition. As shown in Figure 3-1 this model assumes that the reaction products, P*, 
are water-soluble and diffuse away. While valid for short- and medium-chain lipids, this 
assumption is not valid for natural long-chain phospholipids. In fact, accumulation of 
reaction products at the interface can dilute the substrate at the surface, inhibit the 
enzymatic reaction, or accelerate the binding and hence, hydrolysis of the enzyme.1 Thus, 
the theoretical analysis of the interfacial hydrolysis of long-chain lipids is very difficult 
and requires additional kinetic equations to describe the reorganization at the interface 
and consequent inhibition or acceleration of the hydrolysis reaction.1 Due to the 
complexity of the system, this issue has not been addressed; consequently, and simple 
kinetic models developed for soluble products are the only available alternative for 
estimating apparent kinetic parameters for interfacial hydrolysis.1 As described in the 
following steps, we employ the kinetic model for soluble products, proposed by Verger et 
al., to estimate the apparent kinetic parameters of hydrolysis of the long-chain lipid, 1,2-
diphytanoyl-sn-glycero-3-phosphocholine (DiPhyPC), in planar lipid bilayers. Although 
DiPhyPC is not the optimal substrate with regard to the theoretical analysis, long-chain 
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lipids are however, the typical substrates of these enzymes in their physiological 
environment. 
 
Figure 3-1. Adaptation of the Michaelis-Menten model to the interracial hydrolysis of lipids. 
This model  assumes that the reaction products are soluble. This figure is adopted from Baszkin 
and Norde, 2000.1  
 
As shown in Figure 3-1, the enzymatic reaction of an interfacial enzyme occurs at 
the interface and, hence, the concentrations of E*, S, E*S, and P* are expressed as surface 
concentrations ΓE*, ΓS, ΓE*S, and ΓP* (molecules m-2), while the concentrations of E and P 
are expressed as bulk concentrations CE and CP (mol L-1). The following equations 
describe the kinetic model shown in Figure 3-1: 
 
*
1 * 1 *( ) ,E S E S cat E S
d k k k
dt −
Γ
= Γ Γ − + Γ        (5) 
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= Γ          (7) 
 
0 * * ,E E E E SC V C V A A= +Γ +Γ         (8)   
 
where t (min) is time; kP (m min-1) is the adsorption rate constant; kd  (min-1) is the 
desorption rate constant;  and kcat (min-1) is the catalytic rate constant; k1 (m2 molecules-1 
min-1) and             k-1 (min-1); V (m3) is the volume of the aqueous phase and A (m2) is the 
surface area of the lipid-water interface. 
Solving these equations with the initial condition of t = 0, Γp* = 0 and assuming 
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where τ1 is the induction time, describing the establishment of the adsorption-desorption 
steady state; τ2 is the characteristic time of establishment of the interfacial catalytic steady 





− represents the dissociation constant for binding of enzyme to the membrane 







;  and K*m = (kcat + k-1) / k1 (molecules m-2) is the interfacial Michaelis-Menten 
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constant. At steady state condition, the following equation for the hydrolysis rate, υ 

















      (10) 
 
 Eq. (10) can, in principle, be adapted to various interfacial structures.1 We adapt 
this equation to the ion channel-based assay presented in this work. 
In order to employ this equation with mole fractions of substrate and product 
















         (12) 
 
Where XS and XP* are mole fractions of the substrate and product, respectively. 
Combining Eq. (10), (11), and (12) results in the following equation: 
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Assuming that the total concentration of substrate and product at the interface 
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A typical range for the partitioning of the enzyme between the aqueous phase and 
lipid interface at steady state is 2 1
*






.1 In the assay presented here, the 
area to volume ratio of A
V
is estimated to be 0.75 cm-1, considering a chamber with a 
volume of 3 mL and a lipid-water interface with a surface area of ~2.25×10-4 m2 
(obtained by summation of the lipid monolayer formed at the air-water interface and the 
bilayer formed across the aperture). Therefore, the following inequality is fulfilled:1,6 
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Consequently, Eq. (15) can be simplified to the following equation for the hydrolysis rate 













        (17) 
 
3.3. Results and Discussion 





, and the overall kinetic constant 











, of the enzymatic reaction of PLD, we 
plotted the initial hydrolysis rate, υ, of PLD as a function of the enzyme concentration in 








Figure 3-2. Changes in the initial rate of hydrolysis of DiphyPC lipids as a function of PLD 
concentration in the bulk solution of the bilayer chamber. Data is taken from chapter 2. The solid 
line represents the best linear fit (R2 = 0.89, N = 6) to the data. 
 
Fitting the data in Figure 3-2 to a line revealed a positive slope of               
460×103 L mol-1 min-1 for the change in the initial hydrolysis rate as a function of the 
enzyme concentration. According to Eq. (17), the following can be obtained:   
 
3 1 1 22 3 1 1
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×
  (18) 
 
The planar lipid bilayers employed here were composed of DiphyPC lipids which 
corresponded to a mole fraction of substrate, XS, of 1. We determined the binding affinity 
of PLD enzyme for DiphyPC bilayers using surface plasma resonance (SPR) and 
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obtained a dissociation constant of 6150 10  MdK








, we assumed that at an enzyme concentration of 150×10-6 M, half of the area 
that is occupied by lipids in a bilayer at the interface are occupied by the enzyme and 
approximating the size of the enzyme, we estimated the number of the bound enzymes 
and their surface concentration, ΓE*. The PLD enzyme employed in the present assay has 
a molecular weight of ~92 kDa10 and we approximated the dimensions of this enzyme 
based on another 92 kDa protein (a 92 kDa fragment of yeast DNA topoisomerase II)11 
and used its crystal dimensions of 120 Å × 120 Å × 50 Å as an estimate for PLD. 
Assuming a spherical shape for the enzyme, it would cover an area of ~97 nm2 on the 
bilayer. If we consider a square unit area of 1 μm2 and a close hexagonal packing (density 
of 90.7%) of the PLD enzyme at the interface, at maximal binding there would be 
~9.4×103 enzymes per μm2 at the interface. At half-maximal binding, therefore, there 
would be ~4.7×103 enzymes bound per μm2 at the interface, corresponding to an 
approximate surface concentration of ΓE* = 4.7×1015 enzyme molecules m-2.  Thus, at an 








would have a value of 19×106 m-1. 




−= × and XS =1 in Eq. (18) we can obtain the specificity 
constant, which is a measure of catalytic efficiency of the enzyme: 
 









And the apparent interfacial quality, Qm, can be obtained: 
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The interfacial quality, Qm, is a global kinetic constant of the hydrolysis that takes 
into account the influence of the physiochemical properties of the interface on the 
enzyme activity. The value of the interfacial quality obtained here is comparable to the 
previously reported value of 4.2×10-15 cm3 molecules-1 min-1 for hydrolysis of a long-
chain lipid by the enzyme phospholipase A, PLA.1 As mentioned previously, however, 
this value reflects an apparent kinetic constant (as opposed to a “real” kinetic constant) 
due to the error introduced by neglecting the effect of insoluble reaction products on the 
hydrolysis reaction.1 Recently, addition of a lipolytic product acceptor such as α- and β-
cyclodextrin to the aqueous solution was employed to solubilize the products of the 
hydrolysis reaction of PLA enzymes.1 This improved approach increased the value of Qm 
of the hydrolysis of a long-chain lipid by a PLA enzyme by two orders of magnitude. The 




In conclusion, this chapter presents an adaptation of a basic kinetic model to the 
PLD assay presented in chapter 2. Quantitative results of the gramicidin-based assay of 
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PLD combined with this kinetic model made it possible to estimate the kinetic parameters 





, and apparent interfacial quality, Qm, of the PLD 
enzymatic activity.  Future advancements on theoretical analysis of heterogeneous 
catalysis may allow us to improve the estimate of these kinetic parameters. Future studies 
may apply the present kinetic model to the gramicidin-based phospholipase C (PLC) 
assay introduced in chapter 2. Given the possibility of varying the substrate concentration 
in the PLC assay, this kinetic model may make it possible to obtain more detailed kinetic 
information including kcat and the interfacial Michaelis-Menten constant, *mK , for PLC 
enzymatic activity.           
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Chapter 4  
Quantifying Interactions of Electrically-Charged Bioactive Molecules 
with Lipid Membranes Using Gramicidin Channels  
 
Abstract 
 The pharmacologic activity of most drugs involves an initial step of interaction 
with the cell plasma membrane (either by binding to membranes or by crossing 
membranes). This interaction, therefore, plays a role in drug selectivity and efficacy. 
Here, we introduce a gramicidin-based assay to monitor the binding of two electrically-
charged drug molecules imipramine and quinine to planar lipid bilayers. We demonstrate 
that this label-free assay can be employed to quantify the binding of electrically-charged 
molecules to lipid membranes with various lipid compositions.    
 
4.1. Introduction 
Interactions of drug molecules with cell membranes are an important field of 
study due to the significant role of these interactions in the pharmacologic activity of the 
drug.1-3 A large number of drug molecules have ionizable functional groups and at the 
physiological range of pH (5.5–7.5), they are partially or fully charged.1,2 Under these 
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conditions, these molecules are, hence, electrostatically attracted (in the case of 
positively-charged pharmaceuticals) or repelled (in the case of negatively-charged drugs) 
by many biological membranes that are composed of acidic lipids, and carry a net 
negative charge. The interaction of the charged drug molecules with membranes is, 
therefore, of great interest for pharmacology and medicinal chemistry. These interactions 
can be studied by various techniques including fluorescence and radioactive assays.4,5 
Here, we introduce a new approach to monitor the binding of electrically-charged 
molecules to various lipid membranes in real-time and without the need for labeling the 
drug of interest. This assay detects the binding of these molecules to the membrane 
through the changes in the ion conductance of the channel forming peptide gramicidin A 
(gA).6,7 Binding of electrically-charged molecules to a membrane alters the surface 
charge density of the membrane and, hence, influences the local concentration of cations 
near the membrane surface.1,8 Gramicidin is a cation selective channel6,9,10 and as 
previously demonstrated, the single channel conductance of gA, γ, is influenced by the 
local concentration of cations near the channel entrance.11-13 The assay presented here, 
takes advantage of this sensitivity of gA channels and employs these pores to monitor, in 
situ, the changes in the membrane surface charge and hence, binding of the charged 
molecules onto the membrane.  
 
4.2. Results and Discussion 
In order to explore the potential application of a gA-based sensor as a binding 
assay, we formed planar lipid bilayers of neutral and negatively-charged lipids that 
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contained gA pores and monitored the single channel conductance, γ, of these pores upon 
exposure of the lipid bilayer to different concentrations of positively-charged drug 
molecules. In case of neutral membranes, with an initial surface charge of zero, binding 
of positively-charged molecules to the membrane creates a positive surface charge. 
Binding of these drug molecules to negatively-charged membranes with an initial 
negative surface charge reduces the membrane surface charge by countering the effect of 
negative charges on the lipids. In both cases, binding of the positively-charged molecules 
to the membrane leads to a decrease in the concentration of cations close to the 
membrane. We hypothesized that this change in the local concentration of cations would 
have a measurable effect on the conductance of gA channels, and hence, the changes in 
gA conductance would reveal information about these binding events.  
We examined the binding of two positively-charged therapeutic compounds, 
imipramine and quinine. Imipramine (Figure 4-1a) is an amphiphilic drug that belongs to 
a group of drugs termed tricyclic antidepressants (TCAs) that have been used for 
treatment of depression for more than 50 years.4 Having a pKa value of 9.4, these 
therapeutic compounds carry a positive charge in aqueous solution at physiological 
conditions.4 Fisar et al. showed that binding of TCAs to model membranes is strongly 
affected by the lipid composition of model membranes (with Kd values varying from 10 
to1000 nM). This effect was mostly attributed to the role of the negatively-charged 
lipids.4 Quinine (Figure 4-1b) is a natural alkaloid that is isolated from the bark of the 
cinchona tree and has been used for reducing fevers and muscle cramps and for treatment 
of malaria prior to recent development of more effective synthetic drugs.5 Currently, the 
side effects and the resistance to these synthesized drugs, has led to a renewed interest in 
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quinine for treatment of malaria.5 Quinine has a pKa of 8.7 and, under physiological 
condition, bears a positive charge.14   
 
  
                                                                            
Figure 4-1. Molecular structures of (a) imipramine and (b) quinine. 
 
We examined binding of both of these drugs to lipid membranes composed of 
either neutral phosphatidylcholine (PC) lipids or composed of 75 mol% PC and 25 mol% 
negatively-charged phosphatidic acid (PA) lipids. After incorporation of a few gA 
channels (typically 1-6 at any given time), we exposed the planar lipid bilayers to 
gradually increasing concentrations of the charged molecules while monitoring the 
conductance of gA channels. Figure 4-2 illustrates the changes in the single channel 
conductance of gA, γ, in the examined lipid bilayers as a function of the bulk 
concentration of quinine and imipramine. As we hypothesized, these plots show that the 
channel conductance of gA decreased significantly with an increasing concentration of 
the drug in the solution.  
 






Figure 4-2. Changes in the single channel conductance, γ, of gA pores as a function of the 
concentration of the positively-charged drugs in the bulk solution. Data show the mean values of 
γ in lipid bilayers composed of (■) PC lipids and (●) PC and 25 mol% PA lipids as a function of 
the bulk concentration of (a) imipramine and (b) quinine in the bilayer chamber. 
 
As mentioned previously, this decrease in the conductance of gA is an indirect 
result of a change in the surface charge density of the membrane.11-13 Changes in the 
surface charge density of a membrane, according to the Gouy-Chapman theory, lead to 
changes in surface potential of the membrane, which influences the distribution of cations 
and anions in the solution and in vicinity of the membrane.11-13 The effective surface 
charge density, σ (C m-2), is a function of both, the amount of negative lipids and the 
bound positive ions, as described in the following equation:15 
 
0( )( ),neg i i
i
e X z X
A
σ = − +∑         (21) 




where e0 (1.60 × 10-19 C) is the elementary charge; A (m2) is the surface area per lipid 
molecule (assumed to be the same for PC and PA lipids); Xneg is the mole fraction of the 
negatively-charged lipid in the membrane; Xi is the mole fraction of bound ion i (i.e. 
moles of bound ion i per mole of total lipid) with valence zi. This equation assumes that 
negatively-charged lipids carry only one charge per lipid, which was a good 
approximation in our case. 
In order to quantify the binding of these molecules to the membrane, we first 
determined the mole fraction of the bound molecules at the membrane. To relate the 
single channel conductance of gA to the amount of the bound drug to the membrane, we 
first acquired a calibration curve of γ (in units of pS =10-12 Ω-1) as a function of the mole 
fraction of PA, XPA (unitless), in the membrane. In these experiments, as the mole 
fraction of the negatively-charged PA lipids in the membrane increases, the surface 
charge of the membrane becomes more negative and leads to an accumulation of cations 
(in this case, Cs+) near the membrane surface. This increased concentration of Cs+ near 
the membrane surface and the entrance of gA pores, results in an increase in γ. Figure 4-3 
illustrates this calibration curve and Eq. (22) which resulted from the linear fit to the data 
in this figure, describes this calibration curve: 
 
(pS) 118.84 9.46 pS.PAXγ = × +        (22) 
 
The data shown in black and red colors in Figure 4-3 represent two sets of data acquired 
in slightly different recording buffers. The black data that was acquired initially, showed 
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a clear linear relationship between γ and XPA, and the red data revealed that a slight 
change in the recording buffer (while keeping the concentration of Cs+ constant) made no 
significant difference in the form of this relationship. We, hence, employed the exact 
same slope of the linear fit obtained from the data shown in black and only adjusted the 
y-intercept of this line for a fit to the data shown in red (Eq. (22)). Since the data 
presented in this chapter was acquired in the same recording buffer as the red data, we 
employed Eq. (22) to relate the change in the XPA to the measured change in γ.  
  
 
Figure 4-3.  Calibration curve of the single channel conductance, γ, of gA as a function of the 
mole fraction of negatively-charged PA lipids in the membrane. Graph shows the mean values of 
γ in PC lipid bilayers that contained various amounts of PA in a recording buffer that contained 
(■) 10 mM cesium chloride and 10 mM cesium acetate with a pH value of 5.5, and  (●) 20 mM 
cesium chloride and 10 mM HEPES with a pH value of 7.4. Error bars represent the standard 
error of the mean (N ≥ 3). The solid black line represents the best linear fit to the data shown in 
black ( (pS) 118.84 2.50 pS,PAXγ = × +  R
2 = 0.97, N = 7). The resulting black line was shifted 
in the y-axis to fit the data shown in red ( (pS) 118.84 9.46 pSPAXγ = × + ), and the shifted line 




Using this calibration curve, we translated the changes in the single channel 
conductance of gA to the changes in the amount of PA lipids in the membrane. 
Converting γ values in Figure 4-1 to XPA, we observed a similar decrease in XPA as a 
function of the bulk concentration of drug molecules in the bilayer chamber. In the 
experiments with drug molecules, however, the amount of XPA in the membrane was 
constant throughout the experiment, and thus, the apparent change in the XPA (that is 
change predicted by the calibration curve) in fact, reflects the amount of positive ions that 
are bound to the membrane. Therefore, by computing the difference between XPA in the 
examined membrane and the XPA predicted by the calibration curve (XPA, pred.), we 
obtained the amount of bound cations to the membrane, as following: 
 
, . ,PA PA pred i i
i
X X X z− =∑         (23) 
 
where Xi represent the mole fraction of the ith cation bound to the membrane and zi 
represents the valence of the ion. The buffer solution used in the study presented here 
contained 20 mM CsCl and 10 mM HEPES with a pH of 7.4; the major cations in the 
solution included Cs+ and the positively-charged drug molecules. While monovalent 
cations including Cs+ usually do not bind to neutral lipids such as PC,16 these ions bind to 
the headgroup of negatively-charged lipids such as PA.16 Approximating the binding 
constant of Cs+ to PA lipids with the binding constant of Cs+ to the negatively-charged 
phosphatidylserine (PS) lipids (K = 0.05 M-1 corresponding to a dissociation constant of 
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20 M)16, at the low (0.02 M) bulk concentration of Cs+ used in the present experiments, 
the amount of bound Cs+ at the membrane is negligible. Thus, the amount of cations 
bound to the membrane solely reflects the amount of the cationic drug molecules. Eq. 
(23) can, hence, be written as: 
 
, . ,PA PA pred D DX X X z− =         (24) 
 
where XD represents the mole fraction of the charged drug bound to the membrane, and zD 
represents the valence of the charged drug. 
We employed Eq. (22) to compute XPA,pred , and by replacing the obtained values 
of XPA,pred  in Eq. (24), we obtained XD zD  as a function of the drug concentration. Figure 
4-4 illustrates the changes in XD zD as a function of the bulk concentration of the drug for 














 .  
Figure 4-4. Changes in the amount of binding of cationic drug bound to lipid bilayers as a 
function of the concentration of these drugs in the bulk solution. Data shows the mean values of 
XD zD as obtained from Eq. (24) in lipid bilayers composed of (■) PC lipids and (●) 75 mol% PC 
and 25 mol% PA lipids as a function of the bulk concentration of (a) imipramine and (b) quinine 
in the bilayer chamber. 
  
 Imipramine has a pKa value of 9.44 and thus, according to the Henderson–
Hasselbalch equation, at a pH of 7.4, approximately 99% of the drug molecules in bulk 
solution bear a positive charge corresponding to an effective charge of zi, = +0.99. 
Quinine has a pKa value of 8.814 and at pH of 7.4 approximately 96% of the quinine 
molecules in bulk solution bear a positive charge corresponding to an effective charge of 
zi = +0.96. Using these zi values, from the data in Figure 4-4, we obtained the mole 
fraction of the bound drug molecule.  
 Binding of these drug molecules to lipid bilayers can be described by a Langmuir 
binding isotherm: 
 











         (25) 
 
where B (unitless) is the amount of the bound drug (in moles) per mole of lipids at free 
drug concentration of CD (M); Bmax (unitless) represents the maximum amount of drug 
bound per mole of lipid; Kd represents the dissociation constant for the binding of drug 
molecules to the membrane. Given the mole fraction of the bound drug molecule as a 
function of the drug concentration, we can obtain the binding isotherm of these binding 
events. Due to the ion concentration profile in the vicinity of every charged membrane,8 
however, the binding association constant (1/Kd) of charged drug molecules is determined 
not by the bulk concentration of the drugs but by the local concentration of the charged 
drug molecules near the membrane. According to the Boltzmann equation (Eq. (26)), the 
local concentration of any ion at a distance X from the membrane surface, CX (mol L-1), at 
a given electric potential of ΨX (V), can be computed from the bulk concentration of that 






=         (26) 
 
where z is the valence of the ion; F (96,485 C mol-1) is the Faraday constant; R (8.31 N m 
mol-1 K-1) is the gas constant and T (K) is the temperature. Thus, the concentration of the 
cationic form of the drug in the vicinity of the membrane, Cm, can be obtained as 








=         (27) 
 
where Ψ0 (V) represents the surface potential of the membrane. Given the bulk 
concentration of the drug, we need the membrane surface potential to be able to compute 
the local concentration of the drug near the membrane. We obtained the membrane 
surface potential as described in the following steps. 
 Gramicidin channels are permeable to monovalent cations6,9,17 such as Cs+ and K+ 
and the conductance of these pores in the recording buffer used in the present study 
(20 mM CsCl and 10 mM HEPES with a pH of 7.4) is dominated by the passage of Cs+ 
through gA channels with a minor contribution of protons (which are at a concentration 
of 10-7 M). Assuming that the single channel conductance of gA, γ, is linearly 
proportional to the local concentration of the permeant ion Cs+ at the membrane, the 
following relationship can be written:8,18 
 
 [Cs ] .mγ
+∝              (28) 
 
The concentration of Cs+ near the membrane, [Cs+]m, at a given membrane surface 
potential can be obtained by the Boltzmann equation:  
 
0[Cs ] [Cs ] exp( ),m b
zF
RT




where [Cs+]b represents the bulk concentration of cesium ions. Combing Eq. (28) and 
(29) results in: 
 
0[ ] exp( ).b
zFCs
RT
ψγ + −∝         (30) 
  
The ratio of the single channel conductance of gA in two different bilayers, γ1 and γ2, can 
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where [Cs+]b,1 and [Cs+]b,2 are the bulk concentration of cesium ions and given these 











=      (32) 
 
Since the surface potential of a neutral membrane is considered to be zero (ψ0,n = 0), the 
ratio of the single channel conductance of gA in a charged membrane, γC, to the gA 











=      (33) 
 
where ψ0,C  is the surface membrane potential of the charged membrane. Solving Eq. (29) 









=      (34) 
 
Assuming that a lipid membrane composed of PC lipids is completely neutral and has a 
surface potential of 0, we can convert the changes in the single channel conductance of 
gA to the changes in surface potential of the membrane using Eq. (34). Substituting the 
following constant values in Eq. (34) results in Eq. (35): 
 
  z = +1, F = 96,485 C mol-1, R = 8.31 N m mol-1 K-1, T = 298 K 




= − ×      (35) 
 
 Obtaining the membrane surface potential using Eq. (35), we computed the local 
concentration of the drug at the membrane by the Boltzmann equation (Eq. (27)) for 
different bulk concentrations of the drug.  By plotting the mole fraction of the charged 
drug molecules bound to the membrane as a function of the drug concentration near the 
membrane, and fitting the data to Eq. (25), we can obtain the binding dissociation 
constant Kd  and the binding capacity Bmax for these binding events.  
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Figure 4-5 depicts the mole fraction of the bound drug molecules to neutral and 
negatively-charged lipid membranes as a function of the local concentration of the drug 
near the membrane. Values of Kd and Bmax that resulted from best curve fits in  
Figure 4-5 are summarized in Table 4-1. 
   
 
 
Figure 4-5. Changes in the mole fraction of the cationic drug that is bound to lipid membranes as 
a function of the local concentration of the positively-charged drug in the vicinity of the 
membrane. The data show the mean values of the mole fraction of bound drug to lipid bilayers 
composed of (■) PC lipids and (●) 75 mol% PC and 25 mol% PA as a function of the local 
concentration of (a) imipramine and (b) quinine near the membrane. Error bars represent the 
standard error of the mean. Solid curves represent the best fit of the data to the Langmuir 








 where B is the mole faction of bound drug 
molecules per mole of lipids, and CD is the concentration of unbound drug.  
  
 
a)                                                              b) 
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Table 4-1. Parameters of binding of the cationic form of imipramine and quinine to neutral and 
negative-charged lipid bilayers.  












8 ± 5 
12 ± 8 
0.05 ± 0.01 
0.23 ± 0.14 
368 ± 160 
38 ± 21 
0.11 ± 0.07 
0.29 ± 0.20  
 
 
Since this gA-based assay relies on changes in the surface potential of the lipid 
membrane to detect the binding of molecules to the membrane, the resulting binding 
parameters only describe the binding of the charged form of the examined drugs. As 
previously mentioned, under the experimental condition of the present study, about 99% 
of imipramine molecules and 96% of quinine molecules carry a positive charge in the 
bulk solution and the remaining fraction of molecules carry no electrical charge. Having 
their charge lost, this fraction of drug molecules interact differently with the lipid 
membrane and may, for example, accumulate in the hydrophobic core of the membrane. 
Although, we would expect the charged and the uncharged from of drug to reach an 
equilibrium in the membrane as well. This equilibrium will depend on the pka of the drug 
in the membrane environment. It is possible that the uncharged form of the drug is 
solubilized in the membrane which would alter the pka.        
The Kd value of 38 μM that was obtained here for binding of quinine to PC/PA 
bilayers is in relatively good agreement with a previously reported value of Kd = 10 μM 
for binding of quinine to lipid vesicles that contained 100 mol% PA lipids under similar 
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experimental conditions.19 The difference by a factor of ~4 weaker binding determined 
here, might in part be due to the fact that the bilayer contained 25 mol% PA instead of 
100 mol%. A previous study on binding of imipramine to lipid membranes using a 
radioligand binding assay has reported Kd values of 0.01-1.2 μM for binding of this drug 
to PC and PC/PS bilayers.4 While the value of Kd obtained here for binding of 
imipramine to PC/PA bilayers (12 μM) is approximately 10-fold higher than these 
reported values, the Kd obtained for binding of imipramine to PC bilayers (8 μM) is three 
orders of magnitude larger than the reported value of ~10 nM. One possible factor for this 
difference is the inappropriateness of the binding model employed here to describe the 
binding of imipramine to the membrane as the fits in Figure 4-5a do not seem to describe 
the data well. This difference may also be due to the fact that the present gA-based assay 
probes only the binding of the charged fraction of drug. Therefore, the difference 
between the results presented here and reported values may reflect a significant 
difference between the binding affinity of uncharged form of the drug to the membrane 
and that of the charged form of the drug. The difference between the acyl chain structure 
of lipids may also contribute to the difference between the present and previous reports.  
We have also explored the application of this binding assay by monitoring the 
binding of a negatively-charged detergent sodium dodecyl sulfate (SDS) to neutral lipid 
bilayers and, as expected, observed a gradual increase in single channel conductance of 
gA with an increasing concentration of SDS in the bilayer chamber (data not shown). 
This result showed that this gA-based assay may also be employed to detect the binding 





 In conclusion, we introduced a gramicidin-based assay to monitor the binding of 
the cationic form of two therapeutic drugs, quinine and imipramine, to planar lipid 
bilayers. We related the change in the single channel conductance of gA pores to the 
change in the mole fraction of the positively-charged drug molecules bound to the 
membrane. Employing the obtained mole fractions, we quantified the monitored binding 
events and revealed the dissociation constant (Kd) and the maximum binding of drug per 
lipid (Bmax).   
This label-free assay is based on single channel recordings of gA pores and 
monitors, in situ and in real time, the binding of electrically-charged molecules to lipid 
membranes through the changes in surface potential of the membrane. This assay is, 
hence, limited to detection of the charged species in the membrane.  
 
4.4. Experimental Section 
 4.4.1. Materials 
We purchased imipramine hydrochloride, quinine, and SDS from Sigma Aldrich; 
cesium chloride (CsCl) from International Biotechnologies, Inc.; calcium chloride 
(CaCl2), pentane, and hexadecane from Fluka; and HEPES from Fisher Scientific. 
Gramicidin A (gA) was purchased as gramicidin D from Sigma Aldrich and purified by 
silica chromatography as described previously20 to afford a final purity of 97% of gA. We 
purchased the following phospholipids form Avanti Polar Lipids, Inc.: 1,2-diphytanoyl-
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sn-glycero-3-phosphocholine (DiPhyPC), 1,2-diphytanoyl-sn-glycero-3-phosphate 
(sodium salt) (DiPhyPA).  
 
4.4.2. Formation of Planar Lipid Bilayers 
We formed planar lipid bilayers with the “folding technique” in a custom-made 
bilayer setup fabricated in Teflon with two compartments of 3 or 4 mL capacity. We 
separated these two compartments by a thin Teflon film that contained one aperture with 
a diameter of ~100 μm (Eastern Scientific Inc.). We used vacuum grease (Corning) to 
attach the Teflon film to the chamber and to create a water tight seal between the two 
compartments. To facilitate bilayer formation, we pretreated the area surrounding the 
aperture of the Teflon film on each side with 2 μL of 5% (v/v) hexadecane in pentane. 
After addition of 1 mL of appropriate electrolyte (see below) to each compartment, we 
spread 3-5 µL of a lipid solution in pentane (25 mg mL-1 for DiPhyPC or 5 mg mL-1 for 
mixtures containing 90 mol% DiphyPC and 10 mol% phosphatidylinositol) at the air-
water interface of the electrolyte solution and raised the liquid level by adding another 2 
or 3 mL (depending on the compartment size) of electrolyte. Raising the liquid level in 
these two compartments above the aperture in the Teflon film resulted in the formation of 
a lipid bilayer from apposition of two lipid monolayers as described originally by Montal 
and Mueller. If raising the liquid level did not immediately result in formation a bilayer 
over the aperture, we lowered the liquid level in one or both compartments, followed by 
raising the electrolyte solution again. We repeated this cycle until we obtained a bilayer 
with a minimum capacitance of 70 pF. 
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The electrolyte solution for the experiments in this study contained 20 mM cesium 
chloride (CsCl) and 10 mM HEPES with a pH of 7.4. We chose electrolytes with low 
ionic strength for these single channel recordings because the charge-induced local 
increase in cation concentration close to a membrane affects the gA conductance more 
significantly under conditions of low ionic strength compared to conditions of high ionic 
strength.  
 
4.4.3. Single Channel Recordings 
Once a stable lipid bilayer was obtained, we gradually added small volumes (0.1 
µL) of a solution of 10 ng mL-1 gA in isopropanol (Acros Organics) to both 
compartments of the bilayer setup until one to six gA channels were inserted in the 
bilayer at the same time. After each addition of gA, we mixed the bilayer chambers by 
stirring the solutions in both compartments for at least 3 min (we confirmed previously 
that a small droplet of food dye was completely mixed in the setup within 2 min of 
stirring). In these experiments the final concentration of gA in the bilayer chamber was in 
the range of 0.1-2.0 pM. This range of gA concentration corresponds to 0.3-8 femtomoles 
of gA in the chamber with a volume of 3-4 mL; the total amount of lipid in each 
compartment was ~150 nanomoles, leading to a lipid to gA ratio of ~108. To measure the 
single channel conductance of gA pores, we recorded current traces versus time while 
applying different voltages in the range of ±100 mV. We performed these single channel 
recordings in “voltage clamp mode” using Ag/AgCl pellet electrodes (Warner 
Instruments) in both compartments of the bilayer setup. Data acquisition and storage was 
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carried out using a custom software written in Labview by Daniel J. Estes in combination 
with a Geneclamp 500 amplifier from Axon Instruments (set to a gain of 100 mV pA-1 
and a filter cutoff frequency of 2 kHz). The data acquisition board (National Instruments) 
that was connected to the amplifier was set to a sampling frequency of 15 kHz. All 
recordings were carried out at a temperature of ~22º C.  
We performed the analysis of the single channel current traces by computing 
histograms of the currents from the original current versus time traces with Clampfit 9.2 
software (Axon Instruments). From these histograms, we extracted the mean current 
amplitude of gA channel opening and closing events. All conductance values were 
obtained from the slopes of current amplitudes versus voltage (I-V) curves (see the next 
section for more details on this analysis).  
In order to reduce the noise in these single channel recordings, we mounted the 
bilayer setup on a low noise stir plate (Stir-2, Warner Instruments), which was placed on 
a bench top vibration isolation platform (50 BM-4, Minus K Technology) inside a 
Faraday cage from Warner Instruments. In addition, we found that we reached the 
minimum noise level by placing the aforementioned setup on top of a second vibration 
isolation table (63-500 series from TMC) with a Faraday cage. 
 
4.4.4. Monitoring Changes in gA Conductance Induced by Binding of Drugs and 
Statistical Data Analysis 
We gradually exposed a bilayer that contained gA pores to the drug by a step by 
step addition of the drug to the bilayer chamber. After each addition, the bilayer chamber 
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was stirred for 3 min to mix the drug inside the chamber. For each concentration of the 
drug, we recorded current traces at different applied voltages. To analyze these current 
versus time traces, we first obtained a histogram that represented the distribution of 
currents for each current trace. The difference in current between adjacent peaks in these 
histograms represented the current amplitude of single gA channel openings. These 
current amplitudes, therefore, reflect the single channel conductance of gA, γ, at a given 
concentration of the drug. By averaging all current amplitudes within a histogram, we 
obtained the mean current amplitude of gA events and a standard deviation (STD) for this 
mean for each trace for a given drug concentration. We plotted these mean current 
amplitudes as a function of the applied voltage for each concentration. We obtained a 
mean value for single channel conductance of gA, γ, at a given drug concentration from 
the slope of the resulting current versus voltage (I-V) curve in the linear range 
≤ |± 100 mV| of the curve. 
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Chapter 5  
Fabrication of Arrays of Supported Lipid Membranes for Screening of 
Drug-Membrane and Protein-Membrane Interactions 
 
Abstract 
 This chapter describes a rapid, reproducible, and straightforward method to form 
copies of functional membrane arrays with various lipid compositions and the application 
of these arrays for screening of drug-membrane and protein-membrane interactions. We 
employed topographically patterned agarose gels to stamp spatially-addressable arrays of 
supported bilayers on glass and confirmed the fluidity of these membranes by 
fluorescence recovery experiments. We took advantage of the storage capability of 
hydrogels and demonstrate that inking posts on an agarose stamp with extremely small 
volumes (≤ 1 µL) of a solution containing liposomes was sufficient to transfer at least 
100 copies of a membrane array without the need for re-inking. We used stamped 
membrane arrays for screening the interactions of a protein (annexin V) and an anti-
inflammatory drug (nimesulide) with bilayers of various lipid compositions and 
discovered that the interaction of the prescription drug nimesulide with membranes 




 Interest in supported bilayers1-3 includes studies of the dynamic structure of 
membranes,4,5 their self-assembly,5 lipid-protein interactions,5 ligand-receptor 
interactions,5-8 development of membrane-based biosensors,5,9-15 and drug discovery.16 In 
addition, many pharmaceuticals are known to interact with biological membranes and 
assays for testing drug-membrane interactions are important for a better understanding of 
drug activity, targeting, and toxicity.17 In order to use supported bilayers efficiently for 
studying the aforementioned processes, the membranes must be fluid1,16,18,19 and 
mechanically stable19. Techniques currently employed to form arrays of supported  
membranes use deposition of droplets of liposome solution onto surfaces,6,18 vesicle 
fusion from bulk solution onto patterned substrates,20,21 delivery of liposomes by 
microfluidic channels,22,23 and microcontact printing with poly (dimethylsiloxane) 
(PDMS).24 
 Considering the application of membrane arrays for screening protein-membrane 
or drug-membrane interactions, an ideal fabrication method would rapidly create many 
functional copies of an array of different bilayers while consuming minimal amounts of 
lipids. Among the existing methods, microcontact printing has the ability to create many 
spots of membranes in parallel. To prepare arrays with various compositions, however, 
posts of the stamp used for microcontact printing have to be inked individually.  Such an 
inking procedure can be time consuming and introduce heterogeneity in the stamped 
arrays. It would therefore be advantageous if a biocompatible stamp – once inked – 
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would store the inking solution and allow multiple transfers without the need for re-
inking. 
 Here, we demonstrate that stamping with hydrogel stamps allows multiple 
stamping while using minute amounts of material. We fabricated stamps from 4% 
agarose gel, which has a pore size that is sufficiently large to allow for the diffusion of 
macromolecules and small liposomes (the pore size of 2% agarose gel is ~ 470 nm25). 
This capability makes it possible to store inking solution in the stamp while replenishing  
molecules at the surface of the stamp and thus to perform multiple stamping of 
biomolecules.25 Recently agarose stamps26,27 have been applied to pattern arrays of 
proteins,28,29 bacteria,30 and mammalian cells.31 Here we present the first attempt to use 
hydrogel stamps to create functional arrays of fluid lipid membranes. 
 
5.2. Results and Discussion 
 To form arrays of lipid bilayers, we inked each post on the agarose stamp with a 
sub-microliter volume of liposome suspension and after the posts absorbed the solution, 
we placed the inked stamp in contact with glass slides for 5-10 sec (see experimental 
section for details and stamp dimensions). Immediately after removing the stamp we 
immersed the patterned substrates in deionized water or PBS buffer. We hypothesize that 
during stamping, supported membranes form by diffusion of small liposomes (diameter 
20-80 nm)32 through the pores of the agarose stamp and by subsequent spreading of 
liposomes onto the regions of contact with the glass. Since the agarose stamps used in 
this method consisted mostly (≥ 96% w/w) of water, we suggest that the mechanism of 
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bilayer formation was similar to the mechanism of the established method of vesicle 
fusion from solution.16 
We examined the structure of the stamped lipid bilayer spots on the glass 
substrate by atomic force microscopy (AFM) experiments. The AFM results revealed a 
smooth surface of bilayer with scattered defects. Figure 5-1a shows an AFM image of a 
stamped bilayer composed of 99% (w/w) egg PC and 1% (w/w) rh-PE on a glass 
substrate. Figure 5-1b shows a height profile of the stamped bilayer using a defect site as 
a reference.6 The area of the defect sites was ≤ 23 % of the total imaged bilayer area. 
Cross-section analysis of the defects revealed a thickness of 4.3 ± 0.8 nm, which 
corresponds to the height of a single lipid bilayer.6 
 
 
Figure 5-1.  (a) AFM image of a potion of a stamped spot of bilayer composed of 99% (w/w) egg 
PC and 1% (w/w) rh-PE. The area of defects within this image is ~ 14%. (b) Height profile of the 





 To investigate the capability of agarose stamps to store small liposomes, we used 
a stamp which was inked once and stamped 100 times without intermediate re-inking. 
This stamp was inked with a solution of liposomes composed of L-α-phosphatidylcholine 
from chicken egg (egg PC) and 1% (w/w) 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine–rhodamine B sulfonyl) (rh-PE). We found no 
significant loss in the fluorescence intensity of the spots over 100 stamping events 
(Figure 5-2a). Figure 5-2b and c show fluorescent micrographs of membrane arrays on 
glass obtained after 6 and 100 stamping events. To test the fluidity of the stamped 
bilayers, we performed fluorescence recovery after photobleaching (FRAP) experiments 
(see experimental sections for details). Figure 5-2d shows the recovery of a 
photobleached spot in a bilayer of the last (100th) array. Fluorescence recovery of the 
bilayers in this array was similar to the recovery of the bilayers in the 6th array (difference 
in diffusion constant ≤ 5%) indicating that the quality of the stamped arrays remained 
constant over ~100 stamping events. The fluorescence intensity in the photobleached spot 
recovered to ~90% of its original intensity, a value typical for supported membranes of 










Figure 5-2. Fluorescence intensity after stamping of 100 arrays of membranes using a hydrogel 
stamp without intermediate inking and test of bilayer fluidity. Bilayers composed of egg PC and 1 
% (w/w) rh-PE were stamped on glass slides. (a) Mean fluorescence intensity of supported 
bilayers as a function of the number of stamping events. The error bars represent the standard 
deviation of the fluorescence intensity of all spots in each array and the dashed line represents the 
mean fluorescence intensity of the background. The standard deviation of the fluorescence 
intensity within any individual spot was less than 9.5% and from spot to spot in an array it was 
less than 9%. (b) Micrograph of spots of supported bilayers after the 6th and (c) 100th stamping 
event. (d) Fluorescence images from a FRAP experiment performed on the array from the last 
(100th) stamping event after photobleaching for 8 min. 
 
We used a stamp with posts with a diameter of 200 µm to explore the potential of 
this method for producing membrane arrays with high density. Figure 5-3a shows a 
resulting array with a density of 600 membrane spots per cm2. If such a stamp would be 
inked using robotics, it should, in principle, be possible to stamp multiple copies of high-





bilayers with two different fluorescently-labeled lipids. These spots were transferred in 
parallel from the same stamp. 
 
 
Figure 5-3. Stamped high-density array of supported bilayers and membrane arrays with various 
compositions. (a) Fluorescent micrograph of a patterned array of bilayers composed of egg PC 
with 1% (w/w) rh-PE using an agarose stamp with a post size of 200 µm. (b) Fluorescent 
micrograph of an array of bilayers containing egg PC and 1% (w/w) rh-PE (red) and 3% (w/w) 
NBD-PE (green). 
 
To demonstrate the ability of this method to create, in parallel, bilayers with 
different lipid compositions, we transferred arrays of supported membranes using 
liposomes containing 0-50% negatively-charged lipids and 0-50% cholesterol. 
Remarkably, hydrogel-stamping resulted in membrane arrays of high quality on glass 
substrates even when the bilayers contained 50 % negatively-charged lipids (Figure 
5-4a).  
 




Figure 5-4. Binding of the protein annexin V to bilayers with different PS content. (a) 
Micrographs of binding of fluorescently-labeled annexin V to bilayers containing 0, 20, and 50% 
(w/w) DOPS. (b) Increase of fluorescence intensity due to binding of annexin V to an array of 
bilayers with a gradient in DOPS. Binding of annexin V is calcium-dependent; data were 
obtained in (■) 1 mM and (●) 8 mM Ca2+. Error bars represent standard deviations of 
fluorescence intensity. 
 
To study if liposomes with different lipid compositions are transferred 
differentially from the agarose stamp to the glass slide, we inked the posts of a stamp 
with mixtures of two different liposome populations. Liposomes composed of 99% (w/w) 
egg PC and 1% (w/w) rh-PE (population A) and liposomes composed of 50% (w/w) egg 
PC and 50% (w/w) DOPS (population B) were prepared separately and mixed in different 







fluorescently labeled and therefore the fluorescence intensity of the resulting supported 
bilayers represented the percentage of the transferred liposomes from this population. 
Five different mixtures of the two aforementioned liposome populations were used to ink 
the posts on a stamp, the ratios were: 100% A, 0% B; 80% A, 20% B; 50% A, 50% B; 
30% A, 70% B; 0% A, 100% B. Figure 5-5 shows fluorescent micrographs of the 
resulting array and the graph represents the mean fluorescence intensity in the bilayer 
spots which resulted from inking solutions with varying ratios of fluorescently-labeled 
liposomes. These results showed that the fluorescence of the transferred bilayers was 
proportional to the ratio of the two liposome populations in the inking solution, 












Figure 5-5. Transfer of liposomes from a mixture of liposome preparations which were used for 
inking of an agarose stamp. (a) Graph showing the mean fluorescence intensity of bilayers 
transferred from the posts which were inked with mixtures containing different ratios of 
fluorescent liposomes of population A and non-fluorescent liposomes of population B. Error bars 
represent standard deviations of fluorescence intensity. (b) Fluorescent micrograph of the array of 
bilayers with various compositions. Spots of each row have the same composition. The 
corresponding posts on the stamp were inked with (from top) first row: 100% population A, 
second row: 80% population A and 20% population B, third row: 50% population A and 50% 
population B, forth row: 30% population A and 70% population B, and fifth row: 100% 
population B. (c) Fluorescent images of a portion of bilayer spots of the array shown in (b) at 
higher (40×) magnification. 
 
To explore the application of membrane arrays with various compositions for 
screening of protein-membrane interactions, we formed arrays from egg PC with a 
gradient in the negatively-charged lipid, DOPS, and measured the binding of annexin V 
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to theses bilayers. Annexin V is a calcium-dependent binding protein that interacts with 
negatively-charged lipids.33 Figure 5-4a shows micrographs of binding of fluorescently-
labeled annexin V to supported bilayers with three different concentrations of DOPS. 
Figure 5-4b illustrates that binding of annexin V to supported membranes increased with 
increasing concentration of both, DOPS in the bilayer, and calcium ions in solution. 
These results show that stamped arrays of supported membranes can be used effectively 
to quantify protein-membrane interactions. 
  In addition to investigating protein-membrane binding, membrane arrays may be 
useful for screening drug-membrane interactions. These interactions can depend on the 
composition of the lipid membrane17 (e.g. the content of cholesterol) and they can induce 
a change in the fluidity of the bilayer.34 The therapeutic and toxic effects of many drugs 
are affected by interactions with lipid membranes.17,34 To demonstrate the influence of 
the lipid composition on drug-membrane interactions, we studied the fluidity changes 
introduced by a non-steroidal anti-inflammatory drug (NSAID), nimesulide, in bilayers 
with various contents of cholesterol. NSAIDs, (e.g. aspirin or ibuprofen) are the most 
important drugs for treatment of inflammation, pain, and fever.34 
 Lucio et al. reported that nimesulide increases the fluidity in membranes 
composed of egg PC.34 Here, we incubated stamped membrane arrays of egg PC 
containing various cholesterol contents in solutions containing 0, 50, and 100 µM 
nimesulide for 2 hrs and monitored the changes in fluidity by FRAP experiments. Figure 







Figure 5-6. Influence of nimesulide on the fluidity of stamped lipid bilayers with various 
cholesterol contents. Recovery curves of supported lipid bilayers of egg PC and 1 % (w/w) rh-PE 
containing (■) 0 % cholesterol, (●) 20 % cholesterol, and (▲) 50 % cholesterol in the presence of 
(a) 0 µM, (b) 50 µM, and (c) 100 µM nimesulide. 
 
In agreement with Lucio et al.34 We found that 50 µM nimesulide increased the fluidity 
in egg PC membranes. We discovered the same effect with bilayers containing moderate 
cholesterol content (≤ 20%). Surprisingly, however, nimesulide had the opposite effect, 
namely a decrease in fluidity, on bilayers with high cholesterol content (≥ 50%). Also 
unexpectedly, nimesulide decreased the fluidity of all examined bilayers when added at a 
concentration of 100 µM (Figure 5-6c). The diffusion coefficients of fluorescently-





a)                                        b)                                      c) 
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Table 5-1. Diffusion coefficients, D of supported membranes composed of egg PC and 1% (w/w) 
rh-PE with various cholesterol contents in the presence of nimesulide. 
Cholesterol 
content (%) 
D (cm2 s-1) as a function of the 














The errors of the diffusion coefficients are ≤ ±7 %. The errors were obtained by measuring the 
difference between diffusion coefficients of fluorescently-labeled lipids in bilayers made from the 
same lipid composition but stamped on different days. 
 
5.3. Conclusion 
In conclusion, we present a strikingly simple and reproducible method to obtain 
copies of functional membrane arrays from a range of lipids (including up to 50% 
negatively-charged lipids). This method is capable of fabricating at least 100 copies of a 
bilayer array while using only picomolar amounts of lipids per spot – a characteristic that 
may be particularly beneficial for stamping precious membrane preparations that can 
often only be obtained in limited quantities, such as cellular membrane fragments. 
Binding assays with these arrays elucidated an unknown effect of cholesterol on the 
interaction of a prescription drug with bilayers and we expect liposome stamping to be 
very useful for the rapidly growing interest in drug membrane interactions,17,34 protein-
membrane interactions,5 and arrays of membrane proteins.6 
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5.4. Experimental Section 
5.4.1. Fabrication of Agarose Stamps 
 We prepared agarose stamps according to the procedure described by Mayer et 
al.29 Briefly, we heated an aqueous solution containing 4% (w/v) of high-gel strength 
agarose (OmniPur; Merck, Darmstadt, Germany) in 0.15 M KCl to the boiling point and 
cast it onto a patterned PDMS master at room temperature. Then we allowed the solution 
to gel at room temperature and peeled off the PDMS master to obtain the agarose stamps 
(Figure 5-7a). Depending on the desired dimensions of the agarose stamps, we used 
different PDMS masters to mold the stamps. The PDMS master for stamps with posts 
with 1 mm diameter was a replica (positive) of a PDMS replica (negative) of a standard 
1536-well plate (polystyrene) with flat bottoms (Corning, Cambridge, MA, USA).29 We 
also used masters prepared by photolithography29 for stamps with posts with diameter of 
200 and 700 µm. Depending on the PDMS master used for casting, arrays of posts on the 
agarose stamp, were (i) 200 µm in diameter, 130 µm in height, and spaced 200 µm from 
each other, (ii) 700 µm in diameter, 700 µm in height, and spaced 300 µm from each 








Figure 5-7. Schematic representation of the fabrication of agarose stamps, the inking process, and 
the stamping procedure. (a) Casting agarose gel onto a patterned PDMS master and peeling off 
the PDMS master from the agarose gel resulted in a topographically patterned agarose stamp. (b) 
In order to ink the posts of the stamp manually, the stamps were turned upside down such that 
posts were facing upwards and small droplets (~ 0.2 µL) of liposome suspensions were added on 
top of each post. Small liposomes inside the droplet diffused into the agarose gel and the solution 
of the liposome suspension was absorbed by the gel. (c) Supported lipid bilayer spots were 
formed by diffusion of liposomes through the gel and subsequent spreading of these liposomes 
onto the glass slide at the areas of contact between the stamp and glass slide. Stamped membrane 
arrays on glass slides were immersed in water or PBS buffer immediately after removal of the 




5.4.2. Preparation of Liposomes 
 Lipid mixtures used to prepare liposomes were: 99% L-α-phosphatidylcholine 
form chicken egg (egg PC; Sigma Aldrich) and 1% (w/w) 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine–rhodamine B sulfonyl) (rh-PE; Avanti Polar Lipids); 
97% egg PC and 3% NBD-labled PE (NBD-PE; Avanti Polar Lipids); mixtures of egg 
PC / rh-PE or NBD-PE / 1,2-dioleoyl-sn-glycero-3-[phospho-L-serine] (DOPS; Avanti 
Polar Lipids), and mixtures of egg PC / rh-PE / cholesterol (Avanti Polar Lipids). The 
respective mixing ratios are mentioned in the main text. Small unilamellar liposomes 
were produced by tip sonication using a Branson Sonifier 150 (Branson Ultrasonics 
Corporation, Danbury, USA) of 1 mg lipid in 500 µL of an aqueous solution containing 
0.15 M KCl, for 2-6 minutes (with ~ 5 watts output energy). Before sonication, the lipids 
were dissolved in chloroform and 100 µL of a 10 mg/mL lipid solution in chloroform was 
used to deposit a lipid film on the wall of a 5 mL round bottom flask using a rotatory 
evaporator under vacuum (starting form -300 torr and going up to -740 torr). Residual 
traces of chloroform were removed by desiccation under vacuum (~ -740 torr) for at least 
1 hour.  
 
5.4.3. Cleaning of Microscope Glass Slides 
 Microscope glass slides (Microslides, No. 2974, Corning, N.Y.) were cleaned 
with fresh piranha solution (mixture of concentrated sulfuric acid and  30 % hydrogen 
peroxide) followed by washing with deionized water at least eight times and drying at 
180° C for 2 hours. 
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5.4.4. Inking and Stamping Procedure 
 To ink the agarose stamps with 1 mm or 700 µm posts, we turned the stamp 
upside down in a Petri dish containing a solution of 0.15 M KCl, such that ~ ¾ of the 
thickness of the stamp was immersed the KCl solution and the posts (which were facing 
upwards) were out of the KCl solution. We inked these posts individually by pipetting ~ 
0.2 µL of liposome suspension on top of each post (Figure 5-7b). Neighboring posts on 
the same stamp could be inked with different liposome suspensions. Once the solution 
was adsorbed by the hydrogel (typically after ~ 4 minutes), we added another droplet of ~ 
0.2 µL  of solution on top of each post and this process was repeated for 4 or 5 times. In 
case of stamps with smaller posts (200 µm in diameter), we inked the agarose stamp by 
immersing the posts in a solution of liposomes for ~ 30 min. After inking we turned these 
stamps upside down (200 µm posts facing upwards) and after the stamp adsorbed all 
solution, we used it for stamping.  In the beginning of a stamping series, we stamped 4-7 
times on clean glass slides to remove excess solution of liposomes from the stamp.  
 To form arrays of lipid bilayers, we placed the inked agarose stamp in contact 
with clean glass slides for 5-10 sec (Figure 5-7c). After removing the stamp from the 
slides, the glass slides were immediately immersed in water or PBS solution. All 
stamping procedures were carried out at room temperature in a small room with ≥ 55 % 
humidity. We found that carrying out the stamping procedure in humidity < 50 % 
resulted in supported bilayers with reduced fluidity. The stamped spots of lipid bilayers 




5.4.5. Atomic Force Microscopy (AFM) Experiments 
 We performed AFM experiments to examine the structure of the stamped lipid 
bilayers on the glass slides.35 These experiments were carried out on a Nanoscope IIIA 
Multimode AFM (Veeco Metrology) in the tapping mode. All AFM experiments were 
performed in deionized water at room temperature using a commercially available fluid 
cell, sealed by an O-ring. The images were collected at 256 × 256 pixel resolution at a 
scan rate of 2.39 Hz using the Olympus Biolevers tips (Asylum Research). The spring 
constant of the cantilever was 0.027 N/m and the imaging frequency was 7 - 9 kHz. 
  
5.4.6. Fluorescence Recovery after Photobleaching (FRAP) Experiments   
 FRAP experiments were performed on stamped supported lipid bilayers on glass 
slides (immersed in water or PBS) using a Nikon E600FN epifluorescence microscope 
equipped with an Evolution MP (Media Cybernetics, Canada) camera. The rhodamine 
label of lipids was excited using standard filter settings for rhodamine. Using a 40× 
water-immersion objective a spot with a diameter of ~ 30 µm was photobleached for 6-9 
minutes with the aperture of the microscope closed as much as possible and all neutral 
density filters taken out of the light path. Fluorescence recovery of the bleached spot was 
then monitored with the same 40× objective. The recovery process was imaged with the 
aperture open and a ND4 neutral density filter in the light path to minimize further 
photobleaching. FRAP experiments were carried out in a dark room and the shutter for 
excitation was open only during image acquisition to minimize further photobleaching. 
 Images were analyzed by calculating the difference between the mean 
fluorescence intensity of the photobleached spot and a fluorescent spot in the same 
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bilayer (a spot within the bilayer that had not been bleached) and then normalized to the 
maximum difference between these two intensities. Diffusion coefficients of stamped 
membranes were compared to the diffusion coefficient of a control bilayer prepared on 
the same glass slides by the established vesicle fusion method.36 Diffusion coefficients 
were calculated by the equation, D (cm2 s-1) = 0.224 ω2 (cm)2 / t1/2 (s), where ω is the 
radius of the bleached spot and t1/2 is the half time of the fluorescence recovery.37,38 We 
obtained the value of t1/2 from an exponential curve fit through the data. 
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Chapter 6  
Generating Arrays with High Content and Minimal Consumption of 
Functional Membrane Proteins 
 
Abstract 
This chapter introduces a widely-accessible and straight-forward technique for 
fabricating membrane protein arrays. This technique employs topographically-patterned 
agarose gels to deliver various membrane preparations to glass substrates in a rapid and 
parallel fashion. It can fabricate more than 30 identical copies of a membrane protein 
array while requiring only femtomoles of protein. Taking advantage of on-stamp 
preconcentration, it is able to pattern arrays of multilayered membrane spots with more 
than 20-fold increased content of membrane proteins compared to existing methods. 
 
6.1. Introduction 
Membrane proteins play a prominent role in cellular function and therefore attract 
strong interest as therapeutic targets;1-5 a great portion of the currently marketed 
therapeutic drugs target membrane proteins.1,2,4 To identify new drug candidates by high 
throughput screening, the pharmaceutical industry would benefit from arrays that display
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functional membrane proteins.1-5 In addition, supported membranes6-15 as well as arrays 
of membranes,16-25 membrane proteins,1-4,26 or native vesicles5,27 are increasingly 
employed in academic research laboratories for studies of interactions between proteins 
and lipids,28,29 proteins and membrane proteins,1,2,4,26 as well as between therapeutic 
drugs and biomembranes.21,22,30 
Despite their significance, membrane proteins are notoriously difficult to prepare 
in sufficient quantities and in correctly-folded, functional, and pure form.2,3,15,31 
Fabrication of arrays of these proteins has, therefore, remained challenging and limited to 
a few expert research groups.1-4,11,26 Among the fabrication techniques developed to 
date,1-3,26 robotic spotting is most common.2-4 In this method, a robotic pin printer 
deposits small droplets of membrane suspensions onto substrates to create an array of 
membrane proteins.2 Despite its usefulness, this method requires a robotic system and is 
hence not accessible to most academic research laboratories. In contrast, microcontact 
printing20,32-35 is an accessible, simple, and well-established arraying technique that has 
been applied for fabrication of a variety of arrays, including arrays of supported lipid 
bilayers20,34 and arrays of soluble proteins32-34. This technique has not, however, been 
adopted for direct fabrication of arrays of membrane proteins, presumably because 
stamping with poly (dimethylsiloxane) (PDMS) stamps requires drying of the ink on the 
posts of the stamp in order to preserve the fidelity of the micro pattern. In the case of 
preparations of fragile membrane proteins, this drying step can result in protein 
denaturation and is therefore typically avoided.3 
Here we introduce a novel, straight-forward, and efficient method that employs 
hydrogel-based microcontact printing21,28,36-41 to fabricate arrays of various membrane 
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proteins in a parallel and rapid fashion. The unique characteristics of hydrogel stamps 
provide a hydrated and biocompatible environment that makes it possible to employ 
microcontact printing for direct and rapid fabrication of membrane protein arrays. We 
demonstrate the capability of this technique to fabricate these arrays by two distinct 
approaches with complimentary benefits. In one approach, hydrogel stamps store small 
proteoliposomes and deliver them onto glass substrates. This procedure consumes a 
minimal amount of precious membrane preparations while fabricating multiple copies (at 
least 30) of a membrane protein array. In the other approach, which addresses the 
challenge of fabricating arrays from low abundance membrane proteins, hydrogel stamps 
preconcentrate and deliver relatively large membrane fragments (from mammalian cells) 
to bare or chemically-activated glass substrates. This procedure patterns multilayered 
membrane structures with more than 20-fold increased protein contents per area of the 
spot compared to existing methods. We employed the resulting membrane protein arrays 
to carry out ligand-binding assays with a fluorescently-labeled ligand and demonstrated 
excellent signal to background ratio of fluorescence. 
Recently, we introduced a method that used topographically-patterned agarose 
gels to fabricate arrays of various lipid bilayers with up to 600 spots cm-2.21 We 
demonstrated that this method can create more than 100 copies of an array of functional28 
and fluid supported lipid bilayers42 while using only picomoles of lipids.21 This method 
was, however, limited to generating spots of lipid bilayers; it did not generate membrane 
spots that contained embedded transmembrane proteins. Here we expand the scope of this 
method to the important application of generating arrays of membrane proteins that are 
embedded functionally in lipid membranes. In addition, we demonstrate a novel aspect of 
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hydrogel stamps, namely preconcentration of large membrane fragments, that made it 
possible to generate arrays of multilayered membranes with high content of functional 
membrane proteins. 
 
6.2. Results and Discussion 
In order to generate arrays of membrane proteins, we used detergent dialysis to 
reconstitute an integral membrane protein, human tissue factor (TF), into small liposomes 
with a protein to lipid ratio of 1:5000 (containing 3% fluorescently-labeled lipids) and 
used the resulting proteoliposomes to ink an agarose stamp (Figure 6-1a). The small size 
of these proteoliposomes (diameter ~50 nm)43 allowed them to diffuse into agarose 
stamps (364±8 nm pore size44) where these proteoliposomes were stored in a 
biocompatible and hydrated environment. Consequently, the inked stamp could be used 
to pattern 100 copies of a membrane protein array without intermediate re-inking. As 
shown in Figure 6-2a, the comparison between the mean fluorescence intensities of 
stamped membranes (by epifluorescence microscopy) within the 100 arrays revealed no 
significant decrease in the fluorescence intensity of lipids with increasing number of 
stamping event (except for the first 2-5 stamping events in which we always observed 
fluorescence intensities that were higher than the following arrays; this effect was 
probably due to transfer of excess material on the surface of the stamps during the very 
first stamping events). We also examined the fluidity of the stamped membranes by 
performing fluorescence recovery after photobleaching (FRAP) experiments (as 
described previously21) on membrane spots within different stamped arrays. These 
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experiments confirmed the mobility of lipid molecules within the stamped membrane 
spots (Figure 6-2b), indicating that at least 85 stamping events could be performed 




Figure 6-1. Cartoon comparing hydrogel stamping with spotting of membranes. (a) Storage of 
small proteoliposomes inside the posts of a stamp affords multiple printing of single lipid bilayers 
with embedded membrane proteins without intermediate re-inking. (b) Preconcentration of 
relatively large membrane fragments on the posts of the stamp affords patterning of arrays of 
multilayered cell membrane fragments with high protein content. (c) Preparation of droplet-
derived membrane spots by deposition (spotting) of a droplet of a suspension of membrane 
preparations onto substrate. This droplet was incubated for 1h in a humid chamber to avoid 
drying by evaporation. Note, the resulting membrane arrays or spots were immersed in an 




Figure 6-2. Multiple stamping of membrane arrays and comparison of lipids in membrane spots 
of 100 stamped membrane arrays. (a) Mean fluorescence intensity of fluorescently-labeled lipids 
(NBD-PE) in stamped membrane protein arrays as a function of the number of stamping events 
without intermediate re-inking. The error bars represent the standard error of the mean intensities 
of several of the membrane spots within each array. (b) Fluorescent micrographs from a FRAP 
experiment performed on a membrane from the 2nd and 85th stamped arrays. 
 
In order to confirm the presence of TF proteins in these arrays, we added a 
primary antibody (pAb) against TF followed by exposure to a fluorescently-labeled 
secondary antibody (sAb*). Figure 6-2a shows that the fluorescent signal (and hence the 
content of TF in the membranes) remained close to constant during the first 30 stamped 
arrays. We also compared the fluorescent signal of these stamped membrane spots with 
control spots of supported membranes that we prepared by placing small droplets of 
solutions of membrane preparations on glass or γ-aminopropylsilane (GAPS) coated 




we refer to the resulting spots as “droplet-derived spots”, see Experimental Section for 




Figure 6-3. Multiple stamping of a membrane protein array using a stamp that was inked once 
and comparison of stamped membranes with droplet-derived membranes. (a) Mean fluorescence 
intensity of antibodies bound to TF proteins in membrane spots of arrays as a function of the 
number of stamping events. Error bars represent the standard error of the mean intensity of 
several spots in each array. Insets show fluorescent micrographs of two of these arrays. (b) 
Comparison of the fluorescence intensity of labeled-lipids (green) and antibodies bound to TF 
(red) in stamped membranes with droplet-derived membranes. Error bars represent the standard 
deviation of mean fluorescence intensities. 
 
This comparison showed no significant difference between the stamped 




specificity of antibody binding to the TF-containing membrane spots by exposing one of 
these membrane spots only to the sAb* and detected no fluorescent signal in the absence 
of pAb against TF. Figure 6-4 shows fluorescent micrographs of two similar TF-
containing membrane spots. One of these membrane spots was exposed to an anti-TF 
antibody followed by exposure to a fluorescent secondary antibody (Figure 6-4a), while 
the other spot was only exposed to the fluorescently labeled secondary antibody (Figure 




Figure 6-4. Fluorescent micrographs of two TF-containing membrane spots after exposure to (a) 
anti-TF primary antibody and fluorescent secondary antibody, and (b) fluorescent secondary 
antibody only (control experiment). Micrographs in the top row show the signal from the 
fluorescently-labeled lipids (NBD-PE) in these membranes (images taken with FITC filter 
setting). These images confirmed the similarity of these two membrane spots. Micrographs in the 





Stamping of small proteoliposomes, thus, made it possible to generate rapidly up 
to 30 copies of a membrane protein array while using a stamp that was inked only once 
with a total amount of 0.4 picomoles of TF per post of the stamp (i.e. ~13 femtomoles 
corresponding to ~ 470 pg of TF per spot). As shown in the Figure 6-5a, we observed no 
significant loss in fluorescent signal from the membranes within the first 30 stamped 
arrays. During further stamping events, however, this trend changed and the fluorescence 
intensity (and, hence, the amount of TF in membranes) started to decrease in a linear 
fashion. Despite this decrease, the signal that we detected from the antibodies bound to 
TF protein in the membrane spots of the 30th-100th arrays may be sufficient for some 
applications; Figure 6-5b shows a fluorescent micrograph of the 100th stamped array and 
illustrates detectability of the membrane spots in this array even when using non-optimal 
















Figure 6-5. Multiple stamping of membrane arrays and comparison of TF proteins in membrane 
spots of 100 stamped arrays. (a) Mean fluorescence intensity of fluorescent antibodies bound to 
TF proteins in stamped membrane protein arrays as a function of the number of stamping events. 
The error bars represent the standard error of the mean intensities of several of the membrane 
spots within each array. (b) Fluorescent micrographs of the 2nd and 100th stamped membrane 
array. Note, images of the 100th array were acquired with more sensitive camera settings than the 
other images to obtain the fluorescence intensities shown in (a). 
 
The results in Figure 6-2 and Figure 6-5, show that the fluorescent signal from the 
lipids and hence the amount of lipids remained almost constant during 100 stamping 
events while the amount of proteins decreased after 30 stamping events. We attribute this 
difference to the difference in size and mass and, hence, diffusivity of proteoliposomes 
compared to liposomes (without TF protein) in the agarose gel. An increased size and 




other liposomes (that may have a low or no protein content) in the preparation. We, 
therefore, hypothesized that the smaller average size of liposomes without protein 
facilitated their diffusion through the gel and provided a sustained supply for stamping, 
while proteoliposomes diffused slower and therefore provided a limited supply for 
stamping. The long-lasting plateau in intensity from fluorescence of lipids (Figure 6-2a) 
compared to the initial plateau and gradual reduction of signal from antibody-labeled TF 
proteins supports this hypothesis (Figure 6-5a). 
In order to extend this patterning method to membrane preparations that are 
typically used for drug binding studies,2 we obtained membrane fragments from 
mammalian cells that contained the human nicotinic acetylcholine receptor (AChR) and 
reconstituted this transmembrane receptor into small liposomes. We inked agarose 
stamps with these proteoliposomes and stamped multiple arrays of membranes. Using 
epifluorescence microscopy, we found close to constant fluorescence intensity from the 
fluorescent lipids that we included during the reconstitution procedure in the membranes 
of these arrays. Immunofluorescence assays with pAb against AChRs and sAb*, 
however, revealed no detectable AChR in these membranes. We attribute the low 
fluorescent signal to the low initial concentration of AChRs in the original preparation of 
membrane fragments (<1 nM).  
In order to maximize the protein concentration in the membrane preparation while 
simplifying the procedure and keeping the manipulation of membrane proteins to a 
minimum, we used cell membrane fragments directly and omitted the dialysis 
reconstitution step. We, thus, inked individual posts of agarose stamps with suspensions 
of membrane fragments that contained either AChRs or human dopamine transporters 
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(DATs) and printed several membrane arrays on glass or GAPS coated slides. Figure 6‐6a 
and b show fluorescent micrographs of two arrays that were exposed to pAb against 
either AChR or DAT (both pAbs were from rat), followed by incubation with sAb*. The 
remarkably strong fluorescent signal from only one group of membrane spots in each of 
these arrays illustrated the specificity of binding interactions; pAb against AChR did not 
bind to DAT and pAb against DAT did not bind to AChR (Figure 6-6a, b). We compared 
the fluorescent signal of these stamped membrane spots with droplet-derived membrane 
spots. This comparison showed that hydrogel-stamped membrane spots containing AChR 
(Figure 6-6c) resulted in at least 20 times stronger fluorescence intensity upon binding of 
labeled antibodies against AChR compared to the intensity from droplet-derived spots. 
Figure 6-6d illustrates the fluorescence intensities from a similar comparison for DAT-
containing membrane spots, revealing, again, at least 20-fold higher content of DAT in 
stamped spots compared to droplet-derived spots. The remarkably strong fluorescence 
intensity from antibodies bound specifically to AChRs or DATs in membranes of these 
stamped arrays (Figure 6-6a, b) suggested the presence of multilayer membranes with 
concomitant high protein contents in the stamped arrays. We hypothesized that the large 
size of membrane fragments impeded their diffusion into the network of the agarose gel 
(pore diameter of 243±5 nm for a 4% gel)44 and that membrane fragments thus 
preconcentrated at the surface of the posts of the agarose stamps while excess liquid from 
the membrane preparation adsorbed into the gel (Figure 6-1b). Once we brought the 
inked stamps into contact with clean glass slides for 5-20 sec, the agarose posts 
transferred the preconcentrated membrane fragments onto the substrate, forming 




Figure 6-6. Stamped arrays of two different membrane proteins and comparison of stamped spots 
with droplet-derived spots. Fluorescence micrographs of arrays with alternating columns of DAT-
containing and AChR-containing membranes after exposure to fluorescent antibodies against (a) 
AChR, and (b) DAT. (c) Comparison of fluorescence intensity from antibodies (red) or BTX 
(orange) bound to AChRs in stamped membranes with droplet-derived membrane spots. (d) 
Comparison of fluorescence intensity of antibodies bound to DATs in stamped membranes with 
droplet-derived membrane spots. Bar graphs show fluorescence intensities (after background 
subtraction) of stamped spots and droplet-derived spots. Error bars represent standard deviation 
of mean fluorescence intensities. 
 
We confirmed the multilayered structure of these membranes by confocal 
microscopy (Figure 6-7) (see Experimental Section for details). Immunofluorescence 
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assays revealed that the employed stamp delivered almost all membrane fragments during 
the first stamping event; almost no membrane fragments were delivered during the 
following stamping events. This result confirms the hypothesis of preconcentration and 
subsequent multilayer-transfer. 
For applications in the pharmaceutical industry it is important that membrane 
protein arrays can be used to carry out functional binding assays of ligands, agonists, or 
antagonists.2-4 We investigated the suitability of the stamped membrane arrays for these 
assays by probing the binding of a fluorescently-labeled derivative of the neurotoxin α-
bunguratoxin (BTX) to AChRs. Figure 6-6c compares the fluorescent signal from BTX 
bound to AChRs in stamped membranes with the signal from BTX bound to droplet-
derived spots. The fluorescence intensities from bound BTX were in good agreement 
with the results from antibody binding and demonstrated at least a 20-fold higher content 
of AChR in stamped membrane spots compared to droplet-derived spots (Figure 6-6c). 
Moreover, this approach (i) directly employed cell membrane fragments with the benefit 
of minimized processing of membrane preparations, (ii) patterned multilayer spots of 
membranes with high protein contents, and (iii) minimized undesired and potentially 
denaturing interaction of membrane proteins with the supporting substrate1,2,4,8-11,45 due to 







Figure 6-7. Confocal images of stamped membrane fragments containing AChR on a glass slide 
after exposure to fluorescent antibodies. These membrane spots were transferred from a stamp on 
which the posts were inked with 0.2 µL (first row of images), 0.6 µL (second row of images), or 
1 µL (third row of images) of a solution of cell membrane fragments. (a) Top view, and (b) side 
view of rendered z-scans of the stamped membrane spots. (c) Confocal scans of these membrane 
spots at different distances (in z-direction) from the surface of the glass substrate confirming the 
multilayered nature of the spots. Note the exceptionally strong signal to background ratio of these 
multilayered membrane spots. 
 
6.3. Conclusion 
In conclusion, we present the first demonstration of microcontact printing of 
proteoliposomes and cell membrane fragments by taking advantage of the storage and 
preconcentration capability of biocompatible hydrogels. The method presented here is a 
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remarkably simple, efficient, and cost-effective method that requires only standard 
laboratory equipment and chemicals to fabricate membrane protein arrays in any 
laboratory within less than three hours. We carried out ligand-binding assays and showed 
that the resulting supported membrane proteins were functional and retained their binding 
activity. We employed this method for two distinct approaches to fabricate arrays of 
membranes with integral membrane proteins. One approach takes advantage of the 
storage capability of agarose stamps and minimizes the required time and amount of 
membrane proteins by generating multiple copies of a membrane protein array. This 
approach is particularly beneficial when membrane proteins can be reconstituted in 
relatively high concentrations and when fabrication of several copies of a membrane 
protein array is desirable. The other approach preconcentrates membrane fragments to 
generate arrays of multilayered membranes with high contents of embedded proteins and, 
thus, achieves more than 20-fold enhanced detection sensitivity while requiring only 
femtomoles of membrane proteins. This second approach is most beneficial when 
membrane proteins are sensitive to reconstitution or can be obtained only in low 
concentrations. The advantageous characteristics of these two complementary approaches 
make biocompatible hydrogel stamping compelling for fabrication of arrays of precious 
membrane proteins. We expect hydrogel-based microcontact printing of membrane 
protein preparations to be useful for the steadily growing interest in drug-membrane 






6.4. Experimental Section 
6.4.1. Materials 
We obtained high-gel strength agarose powder from OmniPur (Merck, Darmstadt, 
Germany). All the lipids, including 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine 
(POPC), porcine brain L-α-Lysophosphatidylserine (L-α-PS), and 1,2-Dimyristoyl-sn-
Glycero-3-Phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (NBD-PE) were 
obtained from Avanti Polar Lipids (Alabaster, AL, USA). We purchased recombinant 
human tissue factor (TF) and mouse monoclonal anti-TF antibody from Calbiochem (San 
Diego, CA, USA). We obtained cell membrane fragments containing human dopamine 
transporter (DAT) (transporter concentration of ~14.5 nM) and membrane fragments 
containing human acetylcholine receptor (AChR) (receptor concentration of ~1 nM) from 
PerkinElmer Life and Analytical Sciences (Boston, MA, USA). We purchased rat 
monoclonal anti-DAT antibody from Abcam (Cambridge, MA, USA), and rat 
monoclonal anti-AChR antibody from Sigma-Aldrich (St Louis, MO, USA). Alexa-fluor 
555 goat anti-mouse antibody and alexa-fluor 555 goat anti-rat antibody were purchased 
from Molecular probes (Eugene, OR, USA). We purchased the detergent n-octyl-β-D-
glucopyranoside (OG) from Sigma-Aldrich (St Louis, MO, USA) and the blocking 
solution of casein in phosphate buffered solution (PBS) from Pierce (Rockford, IL, 
USA). Buffer A solution contained 100 mM NaCl, 20 mM Hepes/NaOH buffer, pH 7.5, 





6.4.2. Fabrication of Agarose Stamps 
We prepared agarose stamps with a concentration of 2-4% (w/v), as previously 
described.21,39 We used 2% agarose stamps (pore size of 364±8 nm44) for multiple 
stamping applications and 4% agarose stamps (pore size of 243±5 nm44) for 
preconcentration applications. Briefly, we added agarose powder to a solution of 150 mM 
KCl, 10 mM Hepes, pH 7.4 and heated the mixture (in a microwave oven) to the boiling 
point, while shaking the beaker occasionally, until the agarose powder was completely 
dissolved. Then we immediately poured the hot solution onto a patterned PDMS master 
(placed inside a Petri dish) and quickly degassed the solution in a desiccator that was 
connected to a diaphragm vacuum pump to remove all air bubbles from the wells of the 
PDMS master (such bubbles can result in defective posts on the resulting stamp and must 
be removed). The PDMS master which contained wells with 1 mm diameter (and was 
used as the mold for agarose stamps) was a replica (positive) of a PDMS replica 
(negative) of a standard 1536-well plate (polystyrene) with flat bottoms (Corning, 
Cambridge, MA, USA).21,39 The advantage of using a PDMS replica of a 1356-well plate, 
instead of the plate itself, is that the PDMS mold is elastomeric, which facilitates removal 
of the agarose stamp from the mold. We allowed the gel to form at 4˚C for one hour and 
peeled off the PDMS master to obtain topographically patterned agarose stamps. 
 
6.4.3. Preparation of Small Proteoliposomes 
We prepared small proteoliposomes containing human tissue factor (TF) by a 
detergent dialysis method as described by Neuenschwander et al.46 Briefly, we generated 
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a lipid film by depositing a total of 0.65 micromoles of lipids composed of 77% (mol %) 
POPC, 30% L-α-PS, and 3% NBD-PE dissolved in chloroform in a round-bottom flask 
followed by pulling a vacuum while rotating the flask. We hydrated this lipid film with 
100 μL of a freshly prepared solution of 100 mM OG in buffer A. In order to obtain a TF 
to lipid ratio of 1:5000, we added 189 μL of 1 mg mL-1 TF in deionized (DI) water to this 
mixture. The resulting mixed micelles containing lipids, TF, and OG were incubated at 
room temperature for 30 min followed by dialysis with a dialysis cassette (0.1-0.5 mL, 
10,000 molecular weight cutoff) from Pierce in 1 L of buffer A. We replaced the buffer 
solution every 24 h for 72 h.  
 
6.4.4. Preparation of Glass Substrates 
We cleaned all microscope glass slides (pre-cleaned slides from Corning Inc., 
Corning, NY, USA) by immersing them in a freshly prepared Piranha solution (2:1 
concentrated sulfuric acid and 30% hydrogen peroxide) for ~10 min. We rinsed these 
slides with copious amounts of DI water and stored them in DI water until use.  
Glass slides coated with γ-aminopropysilane (GAPS II)47,48 were purchased from Corning 
Inc. and we used them as obtained. 
 
6.4.5. Inking and Stamping Procedure 
We performed the inking and stamping procedure as previously described.21 
Briefly, once the agarose gel formed on the PDMS master, we peeled off the PDMS 
master and placed the resulting agarose stamp in a Petri dish containing water (with the 
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posts facing upwards) such that ~ 2/3 of the height of the stamp was immersed in DI 
water. We inked individual posts of the stamp by manually pipetting small droplets (~ 0.1 
μL) of the desired solutions on top of each post. We often inked each post 2-4 times to 
supply adequate amounts of material (particularly for multiple stamping applications). 
Once no more excess liquid was visible on the surface of the posts, we employed the 
stamp to pattern an array of membranes. After removal of the stamp, we immediately 
immersed the patterned glass or GAPS II slides in water or buffer. For the multiple 
stamping experiments, when we inked the stamps with small proteoliposomes, we carried 
out the stamping procedure in a room with a humidity of >65% to avoid possible 
dehydration. As opposed to stamped arrays from small proteoliposomes, we found that 
stamped arrays from relatively large membrane fragments were not sensitive to humidity 
and we carried out these experiments in a standard laboratory without humidity control. 
We think that the transfer a multilayer of membranes retained adequate humidity to 
prevent dehydration. This characteristic of the novel concept of stamping multilayered 
membrane preparations is advantageous because it simplifies the procedure for stamping 
multilayered membrane arrays. 
 
6.4.6. Preparation of Droplet-Derived Membrane Spots 
We prepared droplet-derived membrane spots that are similar to spots produced 
by the method of robotic spotting,47,48 as control for the stamped membrane spots. As 
reported by Lahiri and coworkers,47,48 in the robotic spotting method, a robotic pin 
deposits small droplets of solutions of membrane preparations on a substrate (mostly, γ-
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aminopropylsilane coated slides (GAPS II)). These authors incubated the patterned 
substrates in a humid chamber for 1 h and then employed them for ligand binding 
assays.47,48 Attempting to follow this procedure to prepare droplet-derived membrane 
spots, we deposited small droplets (0.2-1 µL) of membrane preparations on a clean glass 
slide or on a GAPS II slide. To provide a defined border for these membrane spots, we 
often deposited the droplets inside a poly (dimethyl siloxane) (PDMS) frame (with a 
punched out hole in the center) that we sealed previously on the substrate. We matched 
the type of membrane preparations (small proteoliposomes versus cell membrane 
fragments) as well as the amount of material used to prepare these control membrane 
spots to the membrane preparation that we used to ink posts on the stamps. We left these 
membrane preparations in contact with glass for 1, 10, 40, and 60 min in a chamber with 
>85% humidity to protect the spots from drying (we always checked the droplets at the 
end of this incubation time to confirm that there was still liquid present on the spots). To 
wash away the excess solution of membrane preparations at the end of the incubation 
time, we immersed the entire setup in a large volume (~10 mL) of PBS and stored the 
resulting membrane spots in PBS solution for microscopy, imaging, and binding assays. 
Due to the surprisingly low signals (upon performing immunofluorescence assays) from 
these control experiments with droplet-derived spots, we decided to examine a few 
samples in which we deliberately dried out the droplets that contained the membrane 
preparations. To do so, we left a few droplets in the humid chamber for more than 5 h 
until they dried out and then processed them in the same way as the wet samples. 
Employing the resulting membrane spots on the glass slides for immunofluorescence 
assays, we noticed that this procedure resulted in almost no signal (probably because the 
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membrane was washed away from the substrate during wash steps). In case of GAPS II 
slides, however, immunofluorescence assays revealed a significantly higher signal 
compared to the samples that we kept wet at all times. 
 
6.4.7. Microscopy and Imaging 
To carry out imaging, we used an upright E600FN Nikon microscope equipped 
with an XCite 120 lamp (EXFO Life Sciences, Ontario, Canada) and a Coolsnap camera 
(Photometrics, Tucson, AZ). We acquired images using Metamorph 7 software 
(Universal Imaging, Downingtown, PA). All of the fluorescent micrographs presented in 
this work are false color images. We acquired images of NBD labeled lipids with filter 
settings for fluorescein and images of alexa-fluor 555 labeled antibodies with filter 
settings for rhodamine. We performed confocal microscopy with an inverted TE2000-U 
Nikon microscope equipped with an Argon 488 laser and a Helium-Neon 543 laser and a 
Nikon scan head. Confocal images were acquired by Nikon EZ-C1 3.5 software. (Image 
Systems, Inc., Columbia, MD). 
 
6.4.8. Immunofluorescence Assays 
As mentioned previously, patterned glass or GAPS II slides were immersed in 
PBS immediately after removal of the stamp. After performing epifluorescence 
microscopy on these arrays (to probe the quality of lipids in stamped membranes by 
imaging the fluorescent lipids in these preparations), we incubated these arrays in a 
solution of casein in PBS for 1 h to block the bare glass. We then incubated these arrays 
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in PBS solutions containing either anti-TF antibody (1.5 μg mL-1), anti-DAT antibody 
(5.8 μg mL-1), or anti-AChR antibody (0.75 μg mL-1) followed by a fluorescently labeled 
secondary antibody; we used alexa-fluor 555 goat anti-mouse antibody (5.5 μg mL-1), or 
alexa-fluor 555 goat anti-rat antibody (5 μg mL-1). We carried out the incubation with 
antibodies at room temperature for 5-15 h with the primary antibody and for 1-3 h with 
the secondary antibody. We did not rinse the slides between these incubations and only 
rinsed them with PBS prior to imaging. 
 
6.4.9. Characterization of Multilayered Membranes by Confocal Microscopy 
In order to confirm the multilayer structure of stamped membrane fragments from 
cell preparations, we performed confocal microscopy on these membranes and used 
rendered z-scans of stamped membrane spots to probe the thickness of these spots. Figure 
6-7 shows confocal images of stamped membrane spots that were transferred from a 
stamp on which each post had been inked with different amounts of membrane 
preparations. The membrane spots shown in Figure 6-7a, b, and c were transferred from 
posts that were inked with 0.2 μL, 0.6 μL, and 1 μL of solution of AChR-containing 
membrane fragments, respectively. In order to image one membrane spot completely in 
each image, we employed a 10× objective for this series of confocal images. Figure 6-7c 
shows z-scans of each of these three membrane spots at different distances from the glass 
surface and demonstrates the difference in thickness of these membrane spots. This figure 
clearly illustrates an increase in thickness of stamped membrane spots with increasing 
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amount of membrane preparations used to ink the corresponding posts on the stamp. 
These results confirm the multilayer structure of the stamped membrane spots. 
 
6.4.10.  Physical Properties of Membrane Arrays from Stamping Small 
Proteoliposomes 
 In previous work, we examined the structure and morphology of stamped spots of 
supported lipid bilayers (without embedded membrane proteins) by AFM,21 these 
experiments revealed the presence of a single lipid bilayer on the solid substrate. We 
concluded that liposomes, once transferred to the solid substrate, fused with each other 
and with the surface by rupturing and forming individual supported lipid bilayers. We 
confirmed the presence of a continuous and fluid lipid bilayer within the stamped spots 
by demonstrating fluorescence recovery after photobleaching (FRAP).21 If the liposomes 
would have remained as intact, individual liposomes, then we would not have observed 
recovery of fluorescence in the photobleached spot as demonstrated previously by 
Bourdillon’s group.15,49 Figure 6-2 demonstrates that stamping fluorescent lipids which 
were embedded along with membrane proteins in the small proteoliposomes that we used 
to ink the hydrogel stamps also recovered after photobleaching; this result suggests that 
hydrogel stamping of small proteoliposomes generated confluent membrane spots rather 
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Chapter 7  
Conclusion and Future Work 
 
In this work, we developed two platforms for studying molecular interactions on 
model lipid membranes. The first part of this work introduces an ion channel-based 
sensor for monitoring the activity of membrane-active enzymes and the binding of 
bioactive molecules at the surface of the membrane. The second part of this work 
presented a straightforward approach to fabricate arrays of lipid bilayers and arrays of 
membrane proteins for screening of lipid-protein interactions and drug-membrane 
interactions. The concluding remarks and the future work of each of these two parts of 
this work are discussed in the following sections. 
 
7.1. Gramicidin-Based Sensors for Quantifying Enzyme Activity and 
Molecular Interactions on Membranes 
Gramicidin channel is well-studied ion pore with a great potential for sensing 
applications due to its small size, availability, and the relative ease with which chemical 
modifications on the channel can be performed.1-7 In the first part of this thesis, we 
developed a novel sensor based on gramicidin channels and applied this sensor as an 
enzymatic assay to study the activity of phospholipases C and D and also as a binding 
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assay to screen the binding of quinine and imipramine to lipid membranes. In the 
following section, we mention two potential applications of this gA-based assay.   
 
Monitoring Molecular Interactions through gA Kinetics  
In this work, we demonstrated that gA channels can effectively report the activity 
of phospholipases D and C on lipid bilayers as well as the binding of charged molecules 
to lipid bilayers. To extract information about these interactions on the membrane, we 
monitored only changes in the single channel conductance of gA. Many pharmaceuticals 
are, however, known to alter the packing and order of lipids in the plasma membrane.8 
Interactions of these molecules with cellular membranes may, therefore, result in changes 
in membrane properties such as fluidity.8 Considering the sensitivity of gA channels to 
membrane properties such as thickness and stiffness,7,9 simultaneous screening of 
different aspects of gA channels including their single channel conductance, life time, 
opening and closing probability, and frequency may, in future, reveal more information 
on molecular interactions on the membrane through the changes in one or more of these 
gA characteristics.  
 
Monitoring the Interactions of Hydrophobic Molecules with Membranes   
In Chapter 4, we explored the application of the gA-based sensor developed in 
this thesis for screening the binding of electrically-charged molecules to lipid 
membranes. We demonstrated that the binding of charged molecules to lipid membranes 
results in a change in the surface charge density of the membrane and can be detected 
through the change in the single channel conductance of gA pores. For this application, 
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we assumed that the examined drug molecules bound only to the surface of the lipid 
membrane and did not penetrate into the bilayer and hence, did not alter the surface area 
of the membrane. For molecules with a relatively large hydrophobic part, this penetration 
would not, however, be negligible and may significantly increase the surface area of the 
membrane. In a membrane with a given net charge, an increase in the surface area of the 
membrane would lead to a decrease in the surface charge density of the membrane and 
would influence the gA conductance. Future studies might consider the effect of 
penetration of charged molecules into the bilayer on the conductance of gA and modify 
the theoretical approach of the binding assay presented in Chapter 4 accordingly. Future 
work might also take advantage of this effect to employ this gA-based sensor for probing 
the interactions of neutral molecules that are hydrophobic with charged membranes. 
When a neutral and hydrophobic molecule interacts with a membrane with a known 
amount of charge, although the binding of the neutral molecule to the membrane does not 
alter the net charge on the membrane, we hypothesized that penetration of the molecule 
into the bilayer reduces the surface charge density of the membrane and consequently, the 
conductance of gA. If feasible, this approach will broaden the scope of the presented 
binding assay in Chapter 4 and will enable this gA-based assay to screen the interactions 
of charged and neutral molecules with lipid membranes.   
 
Application as a Flippase Assay 
As demonstrated in Chapter 2, Figure 2-7, the gramicidin-based sensor presented 
in this thesis, could detect the transverse asymmetry in a lipid bilayer. This unique 
capability of this sensor platform may be applicable to study the enzymatic activity of 
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lipid flippases. Flippases are lipid transporters that play a pivotal role in cell homeostasis 
and belong to various subfamilies of the P-type ATPases and ATP-binding cassette 
(ABC) transporters.10-12 These proteins are involved in regulating lipid asymmetry, 
cellular signaling, vesicle budding, and protein synthesis.12 As a result, dysfunction of 
flippases causes different diseases including cholestasis, atherosclerosis, and visual 
impairment.12 Established techniques employed to probe the activity of these proteins 
include fluorescent13-16 and radioactive17-19 assays. These assays rely on 
extraction,14,17,18,20-22 fluorescent quenching,13,15,16,21,22 or hydrolysis23 of the labeled lipids 
in the outer leaflet of liposomes. Most of these techniques are, however, non-continuous 
and require labeling of lipid molecules. While combining some of these techniques (e.g. 
extraction and fluorescent quenching) with the stopped-flow kinetics20,22 or florescence 
resonance energy transfer (FRET)20 has enabled in situ monitoring of flippase activity, 
the need for labeling of lipids has remained the main drawback for this group of assays. 
An attempt to address this issue was recently reported where the activity of a flippase was 
monitored in situ and without labeling through the changes in shape of giant liposomes.24 
The gA-based sensor developed in this thesis might also present a label-free and sensitive 
platform assay for monitoring the activity of flippase proteins in situ and in real-time.  
We have demonstrated that the conductance of gramicidin A (gA) channels is 
affected by electrical charges near the entrance of the channel and not by those near the 
exit of the channel. Since gA is a cation selective channel, the entrance of gA is always 
located in the positively polarized compartment of the bilayer setup and can be switched 
from one compartment to the other based on the polarity of the applied voltage. As such, 
gA channels embedded in an asymmetric lipid bilayer with one leaflet containing charged 
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lipids and one leaflet containing neutral lipids, have two different conductances 
depending on the polarity of the applied voltage. Enzymatic activity of a flippase on a 
lipid bilayer that contains charged lipids would result in a change in charge distribution 
between the two leaflets. This change would lead to a differential behavior in gA 
conductance depending on the polarity of the applied voltage and may, hence, be 
monitored through the single channel conductance of gA pores. 
 
7.2. Hydrogel Stamping for Fabrication of Arrays of Membranes and 
Membrane Proteins 
In summary, hydrogel-based microcontact printing method presented in the 
second part of this thesis is a simple and unique technique that makes it possible to 
fabricate multiple copies of microarrays of membranes with and without membrane 
proteins and even cell membrane fragments while consuming minimal amounts of these 
extremely expensive and hard to obtain biomolecules. The method is designed to prevent 
denaturation of fragile membrane proteins by taking advantage of the biocompatible and 
hydrated nature of agarose gels. This method has the potential to reduce the costs as well 
as to simplify, miniaturize, and accelerate HTS applications for both academic research 
and pharmaceutical drug discovery. In the following section, we mention some of the 
potential applications of hydrogel stamping method as well as the potential studies on this 






Arrays of Membrane Fragments from Human Organ Cells  
We have demonstrated the ability of hydrogel-based microcontact printing to 
pattern arrays of lipid bilayers as well as arrays of cell membrane fragments that 
contained transmembrane proteins. Future work should, therefore, be able to employ this 
unique approach to produce arrays of membrane spots that represent the plasma 
membranes from human organ cells, in a rapid and parallel fashion while consuming 
minimal amounts of these membrane preparations. An array of micron-size membrane 
fragments, each from a different cell type from one of the body organs, would present a 
valuable test platform for drug discovery and development. Such a miniaturized and 
compact chip may be applied for rapid screening of interactions between potential 
therapeutic compounds and cell membranes of various cell types in human body. 
 
Supported Membranes with Raft-Like Domains  
Another future application of hydrogel-based microcontact printing is the 
fabrication of supported membranes that contain raft-like domains. As mentioned 
previously, lipid rafts are microdomains of elevated cholesterol levels within cell 
membranes that play a prominent role in a range of biological processes such as 
endocytosis and cell signaling.25-27 These domains have also been implicated in a number 
of diseases such as AIDS, diabetes, and Alzheimer’s.25-27 While the significant role of 
lipid rafts in different diseases makes them attractive study subjects, their small size, 
divers molecular composition, and dynamic nature make studies of rafts in biological 
membranes challenging. A simple, well-defined, and stable system for investigating these 
microdomains would, therefore, be valuable in the field of biology. The hydrogel 
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stamping method can pattern domains of supported membranes with desired 
compositions of raft-forming lipids. Backfilling the resulting arrays by spreading various 
liposomes between the raft-like domains will form a continuous supported lipid bilayer 
with well-defined model rafts. In this thesis, we demonstrated the ability of hydrogel 
stamps to create multiple copies of a membrane array with various lipid compositions. 
Inking the posts on a hydrogel stamp with various liposomes, therefore, makes it possible 
to create rapidly many arrays of lipid rafts with various compositions. Applying different 
liposome solutions to backfill each stamped array would result in the formation of 
supported lipid membranes that can vary in both, the lipid composition of the raft, and the 
lipid composition of the supporting membrane.  
Such raft-containing membranes can be employed to study the partitioning of 
different proteins into the rafts and the effect of different drugs on rafts. An interesting 
application of these raft-containing membranes is to study the role of lipid rafts in the 
formation of amyloid plaques that are the main hallmarks of the Alzheimer’s disease.25 
Considering the possible role of lipid rafts in a range of other diseases including AIDS, 
diabetes, and asthma,25-27 a well-defined and high-throughput system to study lipid rafts 
may provide a general platform to study the molecular details that are involved in these 
diseases and to find effective therapeutic targets. 
 
Application in Industry 
Hydrogel stamping method, as presented here, is a simple and low-tech technique 
that requires no special equipment, chemical or even surface treatment and makes it 
possible to fabricate multiplexed arrays of membrane preparations in almost any 
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laboratory within few hours. The current hydrogel stamping method, however, requires 
manual pipetting of the ink solutions onto individual posts of a stamp, which may be 
challenging and time-consuming for certain large-scale applications. In order to transfer 
this technology to industrial research, therefore, future work may address this issue by 
employing robotic pin printing technology28 for the inking procedure.   
 
Hybrid Surfaces with Patterned Conductive Polymers  
Furthermore, future work may employ hydrogel stamping to modify solid 
substrates with patterned conducting polymers. Once brought into contact with a 
conductive substrate (e.g. glass coated with gold), a hydrogel stamp that is loaded with 
desired monomers can act as an aqueous solution with a defined shape and contact area. 
Applying an appropriate voltage between the conductive substrate and an electrode 
inserted into the hydrogel stamp would, hence, initiate polymerization at the regions of 
contact between the stamp and the substrate. Given the growing application of conductive 
polymers for biomedical applications, such a controlled patterning method might provide 
a unique tool to create new hybrid substrates.  
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